<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Osteoporosis,Articles with unsourced statements since May 2008,Articles with unsourced statements since September 2007,Articles with unsourced statements since April 2008,Articles with unsourced statements since February 2008,Osteochondropathy,Osseous and chondromatous tumors,Osteochondrodysplasia,1,25-dihydroxycholecalciferol,Acromegaly,Adrenal insufficiency" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Osteoporosis&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Osteoporosis&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Osteoporosis - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Osteoporosis";
		var wgTitle = "Osteoporosis";
		var wgAction = "view";
		var wgArticleId = "22461";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 282051990;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Osteoporosis skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Osteoporosis</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table class="infobox" width="200" cellspacing="0" style="font-size: 95%; text-align:left">
<tr>
<td style="text-align: center; background: lightgrey; font-size: 95%;" colspan="2"><b>Osteoporosis</b><br />
<i>Classification and external resources</i></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-10_codes" title="List of ICD-10 codes" class="mw-redirect">10</a></th>
<td><a href="/wiki/ICD-10_Chapter_M" title="ICD-10 Chapter M" class="mw-redirect">M</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gm80.htm+m80" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gm80.htm+m80" rel="nofollow">80.</a>-<a href="/wiki/ICD-10_Chapter_M" title="ICD-10 Chapter M" class="mw-redirect">M</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gm80.htm+m82" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gm80.htm+m82" rel="nofollow">82.</a></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9</a></th>
<td><a href="http://www.icd9data.com/getICD9Code.ashx?icd9=733.0" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=733.0" rel="nofollow">733.0</a></td>
</tr>
<tr>
<th><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=166710" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=166710" rel="nofollow">166710</a></td>
</tr>
<tr>
<th><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a href="http://www.diseasesdatabase.com/ddb9385.htm" class="external text" title="http://www.diseasesdatabase.com/ddb9385.htm" rel="nofollow">9385</a></td>
</tr>
<tr>
<th><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000360.htm" class="external text" title="http://www.nlm.nih.gov/medlineplus/ency/article/000360.htm" rel="nofollow">000360</a></td>
</tr>
<tr>
<th><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a href="http://www.emedicine.com/med/topic1693.htm" class="external text" title="http://www.emedicine.com/med/topic1693.htm" rel="nofollow">med/1693</a>&#160; <a href="http://www.emedicine.com/ped/topic1683.htm#" class="external text" title="http://www.emedicine.com/ped/topic1683.htm#" rel="nofollow">ped/1683</a> <a href="http://www.emedicine.com/pmr/topic94.htm#" class="external text" title="http://www.emedicine.com/pmr/topic94.htm#" rel="nofollow">pmr/94</a> <a href="http://www.emedicine.com/pmr/topic95.htm#" class="external text" title="http://www.emedicine.com/pmr/topic95.htm#" rel="nofollow">pmr/95</a></td>
</tr>
<tr>
<th><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b></th>
<td><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D010024" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D010024" rel="nofollow">D010024</a></td>
</tr>
</table>
<p><b>Osteoporosis</b> is a <a href="/wiki/Disease" title="Disease">disease</a> of <a href="/wiki/Bone" title="Bone">bone</a> that leads to an increased risk of <a href="/wiki/Bone_fracture" title="Bone fracture">fracture</a>. In <strong class="selflink">osteoporosis</strong> the <a href="/wiki/Bone_mineral_density" title="Bone mineral density" class="mw-redirect">bone mineral density</a> (BMD) is reduced, bone microarchitecture is disrupted, and the amount and variety of <a href="/wiki/Collagen" title="Collagen">non-collagenous</a> proteins in bone is altered. Osteoporosis is defined by the <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO) in women as a bone mineral density 2.5 <a href="/wiki/Standard_deviation" title="Standard deviation">standard deviations</a> below peak bone mass (20-year-old healthy female average) as measured by <a href="/wiki/Dual_energy_X-ray_absorptiometry" title="Dual energy X-ray absorptiometry">DXA</a>; the term "established osteoporosis" includes the presence of a <a href="/wiki/Fragility_fracture" title="Fragility fracture">fragility fracture</a>.<sup id="cite_ref-WHO1994_0-0" class="reference"><a href="#cite_note-WHO1994-0" title=""><span>[</span>1<span>]</span></a></sup> Osteoporosis is most common in women after <a href="/wiki/Menopause" title="Menopause">menopause</a>, when it is called <b>postmenopausal osteoporosis</b>, but may also develop in men, and may occur in anyone in the presence of particular hormonal disorders and other <a href="/wiki/Chronic_(medicine)" title="Chronic (medicine)">chronic</a> diseases or as a result of <a href="/wiki/Medications" title="Medications" class="mw-redirect">medications</a>, specifically <a href="/wiki/Glucocorticoid" title="Glucocorticoid">glucocorticoids</a>, when the disease is called steroid- or <a href="/wiki/Glucocorticoid-induced_osteoporosis" title="Glucocorticoid-induced osteoporosis" class="mw-redirect">glucocorticoid-induced osteoporosis</a> (SIOP or GIOP). Given its influence is the risk of fragility fracture, osteoporosis may significantly affect <a href="/wiki/Life_expectancy" title="Life expectancy">life expectancy</a> and <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a>.</p>
<p>Osteoporosis can be prevented with lifestyle changes and sometimes medication; in people with osteoporosis, treatment may involve both. Lifestyle change includes <a href="/wiki/Fall_prevention" title="Fall prevention">preventing falls</a> and exercise; medication includes <a href="/wiki/Calcium_in_biology" title="Calcium in biology">calcium</a>, <a href="/wiki/Vitamin_D" title="Vitamin D">vitamin D</a>, <a href="/wiki/Bisphosphonate" title="Bisphosphonate">bisphosphonates</a> and several others. Fall-prevention advice includes exercise to tone deambulatory muscles, proprioception-improvement exercises; equilibrium therapies may be included. Exercise with its anabolic effect, may at the same time stop or reverse osteoporosis.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2"><a href="#Fractures"><span class="tocnumber">1.1</span> <span class="toctext">Fractures</span></a></li>
<li class="toclevel-2"><a href="#Falls_risk"><span class="tocnumber">1.2</span> <span class="toctext">Falls risk</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Risk_factors"><span class="tocnumber">2</span> <span class="toctext">Risk factors</span></a>
<ul>
<li class="toclevel-2"><a href="#Nonmodifiable"><span class="tocnumber">2.1</span> <span class="toctext">Nonmodifiable</span></a></li>
<li class="toclevel-2"><a href="#Potentially_modifiable"><span class="tocnumber">2.2</span> <span class="toctext">Potentially modifiable</span></a></li>
<li class="toclevel-2"><a href="#Diseases_and_disorders"><span class="tocnumber">2.3</span> <span class="toctext">Diseases and disorders</span></a></li>
<li class="toclevel-2"><a href="#Medication"><span class="tocnumber">2.4</span> <span class="toctext">Medication</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Diagnosis"><span class="tocnumber">3</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2"><a href="#Dual_energy_X-ray_absorptiometry"><span class="tocnumber">3.1</span> <span class="toctext">Dual energy X-ray absorptiometry</span></a></li>
<li class="toclevel-2"><a href="#Screening"><span class="tocnumber">3.2</span> <span class="toctext">Screening</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Pathogenesis"><span class="tocnumber">4</span> <span class="toctext">Pathogenesis</span></a></li>
<li class="toclevel-1"><a href="#Treatment"><span class="tocnumber">5</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2"><a href="#Medication_2"><span class="tocnumber">5.1</span> <span class="toctext">Medication</span></a></li>
<li class="toclevel-2"><a href="#Nutrition"><span class="tocnumber">5.2</span> <span class="toctext">Nutrition</span></a></li>
<li class="toclevel-2"><a href="#Exercise"><span class="tocnumber">5.3</span> <span class="toctext">Exercise</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Prognosis"><span class="tocnumber">6</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1"><a href="#Epidemiology"><span class="tocnumber">7</span> <span class="toctext">Epidemiology</span></a>
<ul>
<li class="toclevel-2"><a href="#Hip_fractures"><span class="tocnumber">7.1</span> <span class="toctext">Hip fractures</span></a></li>
<li class="toclevel-2"><a href="#Vertebral_fractures"><span class="tocnumber">7.2</span> <span class="toctext">Vertebral fractures</span></a></li>
<li class="toclevel-2"><a href="#Wrist"><span class="tocnumber">7.3</span> <span class="toctext">Wrist</span></a></li>
<li class="toclevel-2"><a href="#Rib_Fractures"><span class="tocnumber">7.4</span> <span class="toctext">Rib Fractures</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Prevention"><span class="tocnumber">8</span> <span class="toctext">Prevention</span></a>
<ul>
<li class="toclevel-2"><a href="#Lifestyle"><span class="tocnumber">8.1</span> <span class="toctext">Lifestyle</span></a></li>
<li class="toclevel-2"><a href="#Medication_3"><span class="tocnumber">8.2</span> <span class="toctext">Medication</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">9</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Organisations"><span class="tocnumber">10</span> <span class="toctext">Organisations</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">11</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">12</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">13</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Signs_and_symptoms" id="Signs_and_symptoms"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a>]</span> <span class="mw-headline">Signs and symptoms</span></h2>
<p>Osteoporosis itself has <a href="/wiki/Asymptomatic" title="Asymptomatic" class="mw-redirect">no specific symptoms</a>; its main consequence is the increased risk of bone fractures. Osteoporotic <a href="/wiki/Fractures" title="Fractures" class="mw-redirect">fractures</a> are those that occur in situations where healthy people would not normally break a bone; they are therefore regarded as <i><a href="/wiki/Fragility_fracture" title="Fragility fracture">fragility fractures</a></i>. Typical fragility fractures occur in the <a href="/wiki/Vertebral_column" title="Vertebral column">vertebral column</a>, <a href="/wiki/Rib" title="Rib">rib</a>, <a href="/wiki/Hip_fracture" title="Hip fracture">hip</a> and <a href="/wiki/Wrist" title="Wrist">wrist</a>.</p>
<p><a name="Fractures" id="Fractures"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=2" title="Edit section: Fractures">edit</a>]</span> <span class="mw-headline">Fractures</span></h3>
<p>The symptoms of a <a href="/wiki/Vertebra" title="Vertebra">vertebral</a> collapse ("<a href="/wiki/Compression_fracture" title="Compression fracture">compression fracture</a>") are sudden <a href="/wiki/Back_pain" title="Back pain">back pain</a>, often with <a href="/wiki/Radiculopathy" title="Radiculopathy">radiculopathic pain</a> (shooting pain due to <a href="/wiki/Nerve" title="Nerve">nerve</a> compression) and rarely with <a href="/wiki/Spinal_cord_compression" title="Spinal cord compression">spinal cord compression</a> or <a href="/wiki/Cauda_equina_syndrome" title="Cauda equina syndrome">cauda equina syndrome</a>. Multiple vertebral fractures lead to a stooped posture, loss of height, and chronic pain with resultant reduction in mobility.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1" title=""><span>[</span>2<span>]</span></a></sup></p>
<p>Fractures of the long bones acutely impair mobility and may require <a href="/wiki/Surgery" title="Surgery">surgery</a>. <a href="/wiki/Hip_fracture" title="Hip fracture">Hip fracture</a>, in particular, usually requires prompt surgery, as there are serious risks associated with a hip fracture, such as <a href="/wiki/Deep_vein_thrombosis" title="Deep vein thrombosis">deep vein thrombosis</a> and a <a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">pulmonary embolism</a>, and increased mortality.</p>
<p><a name="Falls_risk" id="Falls_risk"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=3" title="Edit section: Falls risk">edit</a>]</span> <span class="mw-headline">Falls risk</span></h3>
<p>The increased risk of falling associated with aging leads to fractures of the wrist, spine and hip. The risk of falling, in turn, is increased by impaired eyesight due to any cause (e.g. <a href="/wiki/Glaucoma" title="Glaucoma">glaucoma</a>, <a href="/wiki/Macular_degeneration" title="Macular degeneration">macular degeneration</a>), <a href="/wiki/Balance_disorder" title="Balance disorder">balance disorder</a>, <a href="/wiki/Movement_disorder" title="Movement disorder">movement disorders</a> (e.g. <a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a>), <a href="/wiki/Dementia" title="Dementia">dementia</a>, and <a href="/wiki/Sarcopenia" title="Sarcopenia">sarcopenia</a> (age-related loss of <a href="/wiki/Skeletal_muscle" title="Skeletal muscle">skeletal muscle</a>). <a href="/wiki/Collapse_(medical)" title="Collapse (medical)">Collapse</a> (transient loss of postural tone with or without loss of consciousness) leads to a significant risk of falls; causes of syncope are manifold but may include <a href="/wiki/Cardiac_arrhythmia" title="Cardiac arrhythmia">cardiac arrhythmias</a> (irregular heart beat), <a href="/wiki/Vasovagal_syncope" title="Vasovagal syncope" class="mw-redirect">vasovagal syncope</a>, <a href="/wiki/Orthostatic_hypotension" title="Orthostatic hypotension">orthostatic hypotension</a> (abnormal drop in blood pressure on standing up) and <a href="/wiki/Seizure" title="Seizure">seizures</a>. Removal of obstacles and loose carpets in the living environment may substantially reduce falls. Those with previous falls, as well as those with a gait or balance disorder, are most at risk.<sup id="cite_ref-2" class="reference"><a href="#cite_note-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p><a name="Risk_factors" id="Risk_factors"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=4" title="Edit section: Risk factors">edit</a>]</span> <span class="mw-headline">Risk factors</span></h2>
<p>Risk factors for osteoporotic fracture can be split between non-modifiable and (potentially) modifiable. In addition, there are specific diseases and disorders in which osteoporosis is a recognized complication. Medication use is theoretically modifiable, although in many cases the use of medication that increases osteoporosis risk is unavoidable.</p>
<p><a name="Nonmodifiable" id="Nonmodifiable"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=5" title="Edit section: Nonmodifiable">edit</a>]</span> <span class="mw-headline">Nonmodifiable</span></h3>
<p>The most important risk factors for osteoporosis are advanced age (in both men and women) and <a href="/wiki/Female" title="Female">female</a> sex; <a href="/wiki/Estrogen" title="Estrogen">estrogen</a> deficiency following <a href="/wiki/Menopause" title="Menopause">menopause</a> is correlated with a rapid reduction in <a href="/wiki/Bone_mineral_density" title="Bone mineral density" class="mw-redirect">bone mineral density</a>, while in men a decrease in <a href="/wiki/Testosterone" title="Testosterone">testosterone</a> levels has a comparable (but less pronounced) effect. While osteoporosis occurs in people from all ethnic groups, <a href="/wiki/European_ethnic_groups" title="European ethnic groups" class="mw-redirect">European</a> or <a href="/wiki/Asian_people" title="Asian people">Asian</a> ancestry predisposes for osteoporosis.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3" title=""><span>[</span>4<span>]</span></a></sup> Those with a <a href="/wiki/Family_history_(medicine)" title="Family history (medicine)">family history</a> of fracture or osteoporosis are at an increased risk; the <a href="/wiki/Heritability" title="Heritability">heritability</a> of the fracture as well as low bone mineral density are relatively high, ranging from 25 to 80 percent. There are at least 30 genes associated with the development of osteoporosis.<sup id="cite_ref-Raisz_4-0" class="reference"><a href="#cite_note-Raisz-4" title=""><span>[</span>5<span>]</span></a></sup> Those who have already had a fracture are at least twice as likely to have another fracture compared to someone of the same age and sex.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p><a name="Potentially_modifiable" id="Potentially_modifiable"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=6" title="Edit section: Potentially modifiable">edit</a>]</span> <span class="mw-headline">Potentially modifiable</span></h3>
<ul>
<li>Excess <a href="/wiki/Alcoholic_beverage" title="Alcoholic beverage">alcohol</a> - small amounts of alcohol do not increase osteoporosis risk and may even be beneficial, but chronic heavy drinking (alcohol intake greater than 2 units/day),<sup id="cite_ref-BMJosteoporosis_6-0" class="reference"><a href="#cite_note-BMJosteoporosis-6" title=""><span>[</span>7<span>]</span></a></sup> especially at a younger age, increases risk significantly.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7" title=""><span>[</span>8<span>]</span></a></sup></li>
<li><a href="/wiki/Vitamin_D_deficiency" title="Vitamin D deficiency" class="mw-redirect">Vitamin D deficiency</a><sup id="cite_ref-micronutrients_8-0" class="reference"><a href="#cite_note-micronutrients-8" title=""><span>[</span>9<span>]</span></a></sup> - low circulating Vitamin D is common among the elderly worldwide.<sup id="cite_ref-WHOcriteria_9-0" class="reference"><a href="#cite_note-WHOcriteria-9" title=""><span>[</span>10<span>]</span></a></sup> Mild vitamin D insufficiency is associated with increased <a href="/wiki/Parathyroid_hormone" title="Parathyroid hormone">Parathyroid Hormone (PTH)</a> production. <sup id="cite_ref-WHOcriteria_9-1" class="reference"><a href="#cite_note-WHOcriteria-9" title=""><span>[</span>10<span>]</span></a></sup> PTH increases bone resorption, leading to bone loss. A positive association exists between serum <a href="/wiki/1,25-dihydroxycholecalciferol" title="1,25-dihydroxycholecalciferol" class="mw-redirect">1,25-dihydroxycholecalciferol</a> levels and bone mineral density, while PTH is negatively associated with bone mineral density.<sup id="cite_ref-WHOcriteria_9-2" class="reference"><a href="#cite_note-WHOcriteria-9" title=""><span>[</span>10<span>]</span></a></sup></li>
<li><a href="/wiki/Tobacco_smoking" title="Tobacco smoking">Tobacco smoking</a> - tobacco smoking inhibits the activity of osteoblasts, and is an independent risk factor for osteoporosis.<sup id="cite_ref-BMJosteoporosis_6-1" class="reference"><a href="#cite_note-BMJosteoporosis-6" title=""><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-10" class="reference"><a href="#cite_note-10" title=""><span>[</span>11<span>]</span></a></sup> Smoking also results in increased breakdown of exogenous estrogen, lower body weight and earlier menopause, all of which contribute to lower bone mineral density.<sup id="cite_ref-WHOcriteria_9-3" class="reference"><a href="#cite_note-WHOcriteria-9" title=""><span>[</span>10<span>]</span></a></sup></li>
<li>Low <a href="/wiki/Body_mass_index" title="Body mass index">body mass index</a> - being overweight protects against osteoporosis, either by increasing load or through the hormone <a href="/wiki/Leptin" title="Leptin">leptin</a>.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11" title=""><span>[</span>12<span>]</span></a></sup></li>
<li><a href="/wiki/Malnutrition" title="Malnutrition">Malnutrition</a> - low dietary <a href="/wiki/Calcium" title="Calcium">calcium</a> intake, low dietary intake of vitamins K and C<sup id="cite_ref-micronutrients_8-1" class="reference"><a href="#cite_note-micronutrients-8" title=""><span>[</span>9<span>]</span></a></sup> Also low protein intake is associated with lower peak bone mass during adolescence and lower bone mineral density in elderly populations.<sup id="cite_ref-WHOcriteria_9-4" class="reference"><a href="#cite_note-WHOcriteria-9" title=""><span>[</span>10<span>]</span></a></sup></li>
<li><a href="/wiki/Physical_exercise" title="Physical exercise">Physical inactivity</a> - <a href="/wiki/Bone_remodeling" title="Bone remodeling">bone remodeling</a> occurs in response to physical stress. <a href="/wiki/Weight_bearing" title="Weight bearing">Weight bearing</a> exercise can increase peak bone mass achieved in adolescence.<sup id="cite_ref-WHOcriteria_9-5" class="reference"><a href="#cite_note-WHOcriteria-9" title=""><span>[</span>10<span>]</span></a></sup> In adults, physical activity helps maintain bone mass, and can increase it by 1 or 2%.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since May 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> Conversely, physical inactivity can lead to significant bone loss.<sup id="cite_ref-WHOcriteria_9-6" class="reference"><a href="#cite_note-WHOcriteria-9" title=""><span>[</span>10<span>]</span></a></sup></li>
<li>Excess physical activity - excessive exercise can lead to constant damages to the bones which can cause exhaustion of the structures as described above. There are numerous examples of marathon runners who developed severe osteoporosis later in life. In women, heavy exercise can lead to decreased estrogen levels, which predisposes to osteoporosis. In addition, intensive training without proper compensatory increased nutrition increases the risk.</li>
<li><a href="/wiki/Heavy_metals" title="Heavy metals" class="mw-redirect">Heavy metals</a> - a strong association between <a href="/wiki/Cadmium" title="Cadmium">cadmium</a>, lead and bone disease has been established. Low level exposure to cadmium is associated with an increased loss of bone mineral density readily in both genders, leading to pain and increased risk of fractures, especially in the elderly and in females. Higher cadmium exposure results in <a href="/wiki/Osteomalacia" title="Osteomalacia">osteomalacia</a> (softening of the bone).<sup id="cite_ref-12" class="reference"><a href="#cite_note-12" title=""><span>[</span>13<span>]</span></a></sup></li>
<li>Soft drinks - some studies indicate that <a href="/wiki/Soft_drink" title="Soft drink">soft drinks</a> (many of which contain <a href="/wiki/Phosphoric_acid" title="Phosphoric acid">phosphoric acid</a>) may increase risk of osteoporosis;<sup id="cite_ref-13" class="reference"><a href="#cite_note-13" title=""><span>[</span>14<span>]</span></a></sup> Others suggest soft drinks may displace calcium-containing drinks from the diet rather than directly causing osteoporosis.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup></li>
<li><a href="/wiki/Caffeine" title="Caffeine">Caffeine</a> – contrary to popular belief, there is no evidence linking caffeine to osteoporosis.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15" title=""><span>[</span>16<span>]</span></a></sup></li>
</ul>
<p><a name="Diseases_and_disorders" id="Diseases_and_disorders"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=7" title="Edit section: Diseases and disorders">edit</a>]</span> <span class="mw-headline">Diseases and disorders</span></h3>
<p>Many diseases and disorders have been associated with osteoporosis.<sup id="cite_ref-ICSI_16-0" class="reference"><a href="#cite_note-ICSI-16" title=""><span>[</span>17<span>]</span></a></sup> For some, the underlying mechanism influencing the bone metabolism is straight-forward, whereas for others the causes are multiple or unknown.</p>
<ul>
<li>In general, <a href="/wiki/Immobilization" title="Immobilization">immobilization</a> causes bone loss (following the 'use it or lose it' rule). For example, localized osteoporosis can occur after prolonged immobilization of a fractured limb in a cast. This is also more common in active patients with a high bone turn-over (for example, athletes). Other examples include bone loss during <a href="/wiki/Space_flight" title="Space flight" class="mw-redirect">space flight</a> or in people who are bedridden or wheelchair-bound for various reasons.</li>
<li><a href="/wiki/Hypogonadism" title="Hypogonadism">Hypogonadal</a> states can cause secondary osteoporosis. These include <a href="/wiki/Turner_syndrome" title="Turner syndrome">Turner syndrome</a>, <a href="/wiki/Klinefelter_syndrome" title="Klinefelter syndrome" class="mw-redirect">Klinefelter syndrome</a>, <a href="/wiki/Kallmann_syndrome" title="Kallmann syndrome">Kallmann syndrome</a>, <a href="/wiki/Anorexia_nervosa" title="Anorexia nervosa">anorexia nervosa</a>, <a href="/wiki/Andropause" title="Andropause">andropause</a><sup id="cite_ref-medscapeosteoporosis_17-0" class="reference"><a href="#cite_note-medscapeosteoporosis-17" title=""><span>[</span>18<span>]</span></a></sup>, <a href="/wiki/Hypothalamus" title="Hypothalamus">hypothalamic</a> <a href="/wiki/Amenorrhea" title="Amenorrhea" class="mw-redirect">amenorrhea</a> or <a href="/wiki/Hyperprolactinemia" title="Hyperprolactinemia" class="mw-redirect">hyperprolactinemia</a><sup id="cite_ref-medscapeosteoporosis_17-1" class="reference"><a href="#cite_note-medscapeosteoporosis-17" title=""><span>[</span>18<span>]</span></a></sup>. In females, the effect of hypogonadism is mediated by <a href="/wiki/Estrogen" title="Estrogen">estrogen</a> deficiency. It can appear as early <a href="/wiki/Menopause" title="Menopause">menopause</a> (&lt;45 years) or from prolonged premenopausal amenorrhea (&gt;1 year). A bilateral <a href="/wiki/Oophorectomy" title="Oophorectomy">oophorectomy</a> (surgical removal of the ovaries) or a <a href="/wiki/Premature_ovarian_failure" title="Premature ovarian failure">premature ovarian failure</a> cause deficient estrogen production. In males, <a href="/wiki/Testosterone" title="Testosterone">testosterone</a> deficiency is the cause (for example, andropause or after surgical removal of the <a href="/wiki/Testes" title="Testes" class="mw-redirect">testes</a>).</li>
<li>Endocrine disorders that can induce bone loss include <a href="/wiki/Cushing%27s_syndrome" title="Cushing's syndrome">Cushing's syndrome</a><sup id="cite_ref-WHOcriteria_9-7" class="reference"><a href="#cite_note-WHOcriteria-9" title=""><span>[</span>10<span>]</span></a></sup>, <a href="/wiki/Hyperparathyroidism" title="Hyperparathyroidism">hyperparathyroidism</a><sup id="cite_ref-WHOcriteria_9-8" class="reference"><a href="#cite_note-WHOcriteria-9" title=""><span>[</span>10<span>]</span></a></sup>, <a href="/wiki/Thyrotoxicosis" title="Thyrotoxicosis" class="mw-redirect">thyrotoxicosis</a><sup id="cite_ref-WHOcriteria_9-9" class="reference"><a href="#cite_note-WHOcriteria-9" title=""><span>[</span>10<span>]</span></a></sup>, <a href="/wiki/Hypothyroidism" title="Hypothyroidism">hypothyroidism</a>, <a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">diabetes mellitus</a> type 1 and 2,<sup id="cite_ref-OsteoporosisMen_18-0" class="reference"><a href="#cite_note-OsteoporosisMen-18" title=""><span>[</span>19<span>]</span></a></sup> <a href="/wiki/Acromegaly" title="Acromegaly">acromegaly</a> and <a href="/wiki/Adrenal_insufficiency" title="Adrenal insufficiency">adrenal insufficiency</a>. In <a href="/wiki/Pregnancy" title="Pregnancy">pregnancy</a> and <a href="/wiki/Lactation" title="Lactation">lactation</a>, there can be a reversible bone loss. <sup id="cite_ref-ICSI_16-1" class="reference"><a href="#cite_note-ICSI-16" title=""><span>[</span>17<span>]</span></a></sup></li>
<li><a href="/wiki/Malnutrition" title="Malnutrition">Malnutrition</a>, <a href="/wiki/Parenteral_nutrition" title="Parenteral nutrition" class="mw-redirect">parenteral nutrition</a><sup id="cite_ref-WHOcriteria_9-10" class="reference"><a href="#cite_note-WHOcriteria-9" title=""><span>[</span>10<span>]</span></a></sup> and <a href="/wiki/Malabsorption" title="Malabsorption">malabsorption</a> can lead to osteoporosis. Nutritional and gastrointestinal disorders that can predispose to osteoporosis include <a href="/wiki/Coeliac_disease" title="Coeliac disease">coeliac disease</a><sup id="cite_ref-WHOcriteria_9-11" class="reference"><a href="#cite_note-WHOcriteria-9" title=""><span>[</span>10<span>]</span></a></sup>, <a href="/wiki/Crohn%27s_disease" title="Crohn's disease">Crohn's disease</a>, lactose intolerance, surgery<sup id="cite_ref-medscapeosteoporosis_17-2" class="reference"><a href="#cite_note-medscapeosteoporosis-17" title=""><span>[</span>18<span>]</span></a></sup> (after <a href="/wiki/Gastrectomy" title="Gastrectomy">gastrectomy</a>, <a href="/w/index.php?title=Intestinal_bypass_surgery&amp;action=edit&amp;redlink=1" class="new" title="Intestinal bypass surgery (page does not exist)">intestinal bypass surgery</a> or <a href="/wiki/Bowel_resection" title="Bowel resection">bowel resection</a>) and severe <a href="/wiki/Liver_disease" title="Liver disease">liver disease</a> (especially <a href="/wiki/Primary_biliary_cirrhosis" title="Primary biliary cirrhosis">primary biliary cirrhosis</a>)<sup id="cite_ref-medscapeosteoporosis_17-3" class="reference"><a href="#cite_note-medscapeosteoporosis-17" title=""><span>[</span>18<span>]</span></a></sup>. Patients with <a href="/wiki/Bulimia" title="Bulimia" class="mw-redirect">bulimia</a> can also develop osteoporosis. Those with an otherwise adequate calcium intake can develop osteoporosis due to the inability to absorb calcium and/or vitamin D. Other micro-nutrients such as <a href="/wiki/Vitamin_K" title="Vitamin K">vitamin K</a> or <a href="/wiki/Vitamin_B12_deficiency" title="Vitamin B12 deficiency">vitamin B12 deficiency</a> may also contribute.</li>
<li>Patients with rheumatologic disorders like <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a><sup id="cite_ref-medscapeosteoporosis_17-4" class="reference"><a href="#cite_note-medscapeosteoporosis-17" title=""><span>[</span>18<span>]</span></a></sup>, <a href="/wiki/Ankylosing_spondylitis" title="Ankylosing spondylitis">ankylosing spondylitis</a><sup id="cite_ref-medscapeosteoporosis_17-5" class="reference"><a href="#cite_note-medscapeosteoporosis-17" title=""><span>[</span>18<span>]</span></a></sup>, <a href="/wiki/Systemic_lupus_erythematosus" title="Systemic lupus erythematosus">systemic lupus erythematosus</a> and polyarticular <a href="/wiki/Juvenile_idiopathic_arthritis" title="Juvenile idiopathic arthritis">juvenile idiopathic arthritis</a> are at increased risk of osteoporosis, either as part of their disease or because of other risk factors (notably corticosteroid therapy). Systemic diseases such as <a href="/wiki/Amyloidosis" title="Amyloidosis">amyloidosis</a> and <a href="/wiki/Sarcoidosis" title="Sarcoidosis">sarcoidosis</a> can also lead to osteoporosis.</li>
<li><a href="/wiki/Renal_insufficiency" title="Renal insufficiency" class="mw-redirect">Renal insufficiency</a> can lead to <a href="/wiki/Osteodystrophy" title="Osteodystrophy">osteodystrophy</a>.</li>
<li>Hematologic disorders linked to osteoporosis are <a href="/wiki/Multiple_myeloma" title="Multiple myeloma">multiple myeloma</a><sup id="cite_ref-medscapeosteoporosis_17-6" class="reference"><a href="#cite_note-medscapeosteoporosis-17" title=""><span>[</span>18<span>]</span></a></sup> and other <a href="/wiki/Monoclonal_gammopathy" title="Monoclonal gammopathy">monoclonal gammopathies</a>,<sup id="cite_ref-OsteoporosisMen_18-1" class="reference"><a href="#cite_note-OsteoporosisMen-18" title=""><span>[</span>19<span>]</span></a></sup> <a href="/wiki/Lymphoma" title="Lymphoma">lymphoma</a> and <a href="/wiki/Leukemia" title="Leukemia">leukemia</a>, <a href="/wiki/Mastocytosis" title="Mastocytosis">mastocytosis</a><sup id="cite_ref-medscapeosteoporosis_17-7" class="reference"><a href="#cite_note-medscapeosteoporosis-17" title=""><span>[</span>18<span>]</span></a></sup>, <a href="/wiki/Hemophilia" title="Hemophilia" class="mw-redirect">hemophilia</a>, <a href="/wiki/Sickle-cell_disease" title="Sickle-cell disease">sickle-cell disease</a> and <a href="/wiki/Thalassemia" title="Thalassemia">thalassemia</a>.</li>
<li>Several inherited disorders have been linked to osteoporosis. These include <a href="/wiki/Osteogenesis_imperfecta" title="Osteogenesis imperfecta">osteogenesis imperfecta</a><sup id="cite_ref-medscapeosteoporosis_17-8" class="reference"><a href="#cite_note-medscapeosteoporosis-17" title=""><span>[</span>18<span>]</span></a></sup>, <a href="/wiki/Marfan_syndrome" title="Marfan syndrome">Marfan syndrome</a><sup id="cite_ref-medscapeosteoporosis_17-9" class="reference"><a href="#cite_note-medscapeosteoporosis-17" title=""><span>[</span>18<span>]</span></a></sup>, <a href="/wiki/Hemochromatosis" title="Hemochromatosis" class="mw-redirect">hemochromatosis</a><sup id="cite_ref-WHOcriteria_9-12" class="reference"><a href="#cite_note-WHOcriteria-9" title=""><span>[</span>10<span>]</span></a></sup>, <a href="/wiki/Hypophosphatasia" title="Hypophosphatasia">hypophosphatasia</a>, <a href="/wiki/Glycogen_storage_disease" title="Glycogen storage disease">glycogen storage diseases</a>, <a href="/wiki/Homocystinuria" title="Homocystinuria">homocystinuria</a><sup id="cite_ref-medscapeosteoporosis_17-10" class="reference"><a href="#cite_note-medscapeosteoporosis-17" title=""><span>[</span>18<span>]</span></a></sup>, <a href="/wiki/Ehlers-Danlos_syndrome" title="Ehlers-Danlos syndrome">Ehlers-Danlos syndrome</a><sup id="cite_ref-medscapeosteoporosis_17-11" class="reference"><a href="#cite_note-medscapeosteoporosis-17" title=""><span>[</span>18<span>]</span></a></sup>, <a href="/wiki/Porphyria" title="Porphyria">porphyria</a>, <a href="/wiki/Menkes_disease" title="Menkes disease">Menkes' syndrome</a>, <a href="/wiki/Epidermolysis_bullosa" title="Epidermolysis bullosa">epidermolysis bullosa</a> and <a href="/wiki/Gaucher%27s_disease" title="Gaucher's disease">Gaucher's disease</a>.</li>
<li>People with <a href="/wiki/Scoliosis" title="Scoliosis">scoliosis</a> <a href="/wiki/Idiopathic" title="Idiopathic">of unknown cause</a> also have a higher risk of osteoporosis. Bone loss can be a feature of <a href="/wiki/Complex_regional_pain_syndrome" title="Complex regional pain syndrome">complex regional pain syndrome</a>. It is also more frequent in people with <a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a> and <a href="/wiki/Chronic_obstructive_pulmonary_disease" title="Chronic obstructive pulmonary disease">chronic obstructive pulmonary disease</a>.</li>
</ul>
<p><a name="Medication" id="Medication"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=8" title="Edit section: Medication">edit</a>]</span> <span class="mw-headline">Medication</span></h3>
<p>Certain medications have been associated with an increase in osteoporosis risk; only steroids and anticonvulsants are classically associated, but evidence is emerging with regard to other drugs.</p>
<ul>
<li><a href="/wiki/Steroid-induced_osteoporosis" title="Steroid-induced osteoporosis">Steroid-induced osteoporosis</a> (SIOP) arises due to use of <a href="/wiki/Glucocorticoid" title="Glucocorticoid">glucocorticoids</a> - analogous to Cushing's syndrome and involving mainly the axial skeleton. The synthetic glucocorticoid prescription drug <a href="/wiki/Prednisone" title="Prednisone">prednisone</a> is a main candidate after prolonged intake. Some professional guidelines recommend prophylaxis in patients who take the equivalent of more than 30&#160;mg hydrocortisone (7.5&#160;mg of prednisolone), especially when this is in excess of three months.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19" title=""><span>[</span>20<span>]</span></a></sup> Alternate day use may not prevent this complication.<sup id="cite_ref-GIOP_20-0" class="reference"><a href="#cite_note-GIOP-20" title=""><span>[</span>21<span>]</span></a></sup></li>
<li><a href="/wiki/Barbiturate" title="Barbiturate">Barbiturates</a>, <a href="/wiki/Phenytoin" title="Phenytoin">phenytoin</a> and some other enzyme-inducing <a href="/wiki/Antiepileptic" title="Antiepileptic" class="mw-redirect">antiepileptics</a> - these probably accelerate the metabolism of vitamin D. <sup id="cite_ref-21" class="reference"><a href="#cite_note-21" title=""><span>[</span>22<span>]</span></a></sup></li>
<li><a href="/wiki/L-Thyroxine" title="L-Thyroxine" class="mw-redirect">L-Thyroxine</a> over-replacement may contribute to osteoporosis, in a similar fashion as <a href="/wiki/Thyrotoxicosis" title="Thyrotoxicosis" class="mw-redirect">thyrotoxicosis</a> does.<sup id="cite_ref-ICSI_16-2" class="reference"><a href="#cite_note-ICSI-16" title=""><span>[</span>17<span>]</span></a></sup> This can be relevant in subclinical hypothyroidism.</li>
<li>Several drugs induce <a href="/wiki/Hypogonadism" title="Hypogonadism">hypogonadism</a>, for example <a href="/wiki/Aromatase_inhibitors" title="Aromatase inhibitors" class="mw-redirect">aromatase inhibitors</a> used in breast cancer, <a href="/wiki/Methotrexate" title="Methotrexate">methotrexate</a> and other anti-metabolite drugs, <a href="/wiki/Depo-Provera" title="Depo-Provera">depot progesterone</a> and <a href="/wiki/Gonadotropin-releasing_hormone_agonist" title="Gonadotropin-releasing hormone agonist">gonadotropin-releasing hormone agonists</a>.</li>
<li><a href="/wiki/Anticoagulant" title="Anticoagulant">Anticoagulants</a> - long-term use of heparin is associated with a decrease in bone density,<sup id="cite_ref-22" class="reference"><a href="#cite_note-22" title=""><span>[</span>23<span>]</span></a></sup> and <a href="/wiki/Warfarin" title="Warfarin">warfarin</a> (and related coumarins) have been linked with an increased risk in osteoporotic fracture in long-term use.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23" title=""><span>[</span>24<span>]</span></a></sup></li>
<li><a href="/wiki/Proton_pump_inhibitors" title="Proton pump inhibitors" class="mw-redirect">Proton pump inhibitors</a> - these drugs inhibit the production of <a href="/wiki/Gastric_acid" title="Gastric acid">stomach acid</a>; it is thought that this interferes with calcium absorption.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24" title=""><span>[</span>25<span>]</span></a></sup> Chronic <a href="/wiki/Phosphate" title="Phosphate">phosphate</a> binding may also occur with <a href="/wiki/Aluminium" title="Aluminium">aluminium</a>-containing <a href="/wiki/Antacids" title="Antacids" class="mw-redirect">antacids</a>.<sup id="cite_ref-ICSI_16-3" class="reference"><a href="#cite_note-ICSI-16" title=""><span>[</span>17<span>]</span></a></sup></li>
<li><a href="/wiki/Thiazolidinedione" title="Thiazolidinedione">Thiazolidinediones</a> (used for diabetes) - <a href="/wiki/Rosiglitazone" title="Rosiglitazone">rosiglitazone</a> and possibly <a href="/wiki/Pioglitazone" title="Pioglitazone">pioglitazone</a>, inhibitors of <a href="/wiki/Peroxisome_proliferator-activated_receptor_gamma" title="Peroxisome proliferator-activated receptor gamma">PPARγ</a>, have been linked with an increased risk of osteoporosis and fracture.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25" title=""><span>[</span>26<span>]</span></a></sup></li>
<li>Chronic <a href="/wiki/Lithium" title="Lithium">lithium</a> therapy has been associated with osteoporosis.<sup id="cite_ref-ICSI_16-4" class="reference"><a href="#cite_note-ICSI-16" title=""><span>[</span>17<span>]</span></a></sup></li>
</ul>
<p><a name="Diagnosis" id="Diagnosis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=9" title="Edit section: Diagnosis">edit</a>]</span> <span class="mw-headline">Diagnosis</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Bone_density_scanner.jpg" class="image" title="A scanner used to measure bone density with dual energy X-ray absorptiometry."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/3/3a/Bone_density_scanner.jpg/180px-Bone_density_scanner.jpg" width="180" height="240" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Bone_density_scanner.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
A scanner used to measure bone density with <a href="/wiki/Dual_energy_X-ray_absorptiometry" title="Dual energy X-ray absorptiometry">dual energy X-ray absorptiometry</a>.</div>
</div>
</div>
<p>The diagnosis of osteoporosis is made on measuring the <a href="/wiki/Bone_mineral_density" title="Bone mineral density" class="mw-redirect">bone mineral density</a> (BMD). The most popular method is dual energy X-ray absorptiometry (DXA or DEXA). In addition to the detection of abnormal BMD, the diagnosis of osteoporosis requires investigations into potentially modifiable underlying causes; this may be done with <a href="/wiki/Blood_test" title="Blood test">blood tests</a> and <a href="/wiki/X-ray" title="X-ray">X-rays</a>. Depending on the likelihood of an underlying problem, investigations for <a href="/wiki/Cancer" title="Cancer">cancer</a> with <a href="/wiki/Metastasis" title="Metastasis">metastasis</a> to the bone, <a href="/wiki/Multiple_myeloma" title="Multiple myeloma">multiple myeloma</a>, <a href="/wiki/Cushing%27s_disease" title="Cushing's disease" class="mw-redirect">Cushing's disease</a> and other above mentioned causes may be performed.</p>
<p><a name="Dual_energy_X-ray_absorptiometry" id="Dual_energy_X-ray_absorptiometry"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=10" title="Edit section: Dual energy X-ray absorptiometry">edit</a>]</span> <span class="mw-headline">Dual energy X-ray absorptiometry</span></h3>
<p><a href="/wiki/Dual_energy_X-ray_absorptiometry" title="Dual energy X-ray absorptiometry">Dual energy X-ray absorptiometry</a> (DXA, formerly DEXA) is considered the <a href="/wiki/Gold_standard_(test)" title="Gold standard (test)">gold standard</a> for the diagnosis of osteoporosis. Osteoporosis is diagnosed when the <a href="/wiki/Bone_density" title="Bone density">bone mineral density</a> is less than or equal to 2.5 standard deviations below that of a young adult reference population. This is translated as a <a href="/wiki/Bone_density#T-score" title="Bone density">T-score</a>. The <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> has established the following diagnostic guidelines:<sup id="cite_ref-WHO1994_0-1" class="reference"><a href="#cite_note-WHO1994-0" title=""><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-WHOcriteria_9-13" class="reference"><a href="#cite_note-WHOcriteria-9" title=""><span>[</span>10<span>]</span></a></sup></p>
<ul>
<li><a href="/wiki/Bone_density#T-score" title="Bone density">T-score</a> -1.0 or greater is "normal"</li>
<li>T-score between -1.0 and -2.5 is "low bone mass" (or "<a href="/wiki/Osteopenia" title="Osteopenia">osteopenia</a>")</li>
<li>T-score -2.5 or below is osteoporosis</li>
</ul>
<p>When there has also been an osteoporotic fracture (also termed "low trauma-fracture" or "fragility fracture"), defined as one that occurs as a result of a fall from a standing height, the term "severe or established" osteoporosis is used.<sup id="cite_ref-WHO1994_0-2" class="reference"><a href="#cite_note-WHO1994-0" title=""><span>[</span>1<span>]</span></a></sup></p>
<p>The International Society for Clinical Densitometry takes the position that a diagnosis of osteoporosis in men under 50 years of age should not be made on the basis of densitometric criteria alone. It also states that for pre-menopausal women, Z-scores (comparison with age group rather than peak bone mass) rather than T-scores should be used, and that the diagnosis of osteoporosis in such women also should not be made on the basis of densitometric criteria alone.<sup id="cite_ref-pmid14742881_26-0" class="reference"><a href="#cite_note-pmid14742881-26" title=""><span>[</span>27<span>]</span></a></sup></p>
<p><a name="Screening" id="Screening"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=11" title="Edit section: Screening">edit</a>]</span> <span class="mw-headline">Screening</span></h3>
<p>The <a href="/wiki/U.S._Preventive_Services_Task_Force" title="U.S. Preventive Services Task Force">U.S. Preventive Services Task Force</a> (USPSTF) recommended in 2002 that all women 65 years of age or older should be <a href="/wiki/Screening_(medicine)" title="Screening (medicine)">screened</a> with bone densitometry.<sup id="cite_ref-pmid12230355_27-0" class="reference"><a href="#cite_note-pmid12230355-27" title=""><span>[</span>28<span>]</span></a></sup> The Task Force recommends screening only those women ages 60 to 64 years of age who are at increased risk. The best risk factor for indicating increased risk is lower body weight (weight &lt; 70&#160;kg), with less evidence for smoking or family history. There was insufficient evidence to make recommendations about the optimal intervals for repeated screening and the appropriate age to stop screening. <a href="/wiki/Clinical_prediction_rules" title="Clinical prediction rules" class="mw-redirect">Clinical prediction rules</a> are available to guide selection of women ages 60-64 for screening. The Osteoporosis Risk Assessment Instrument (ORAI) may be the most <a href="/wiki/Sensitivity_(tests)" title="Sensitivity (tests)" class="mw-redirect">sensitive</a> strategy<sup id="cite_ref-pmid17552058_28-0" class="reference"><a href="#cite_note-pmid17552058-28" title=""><span>[</span>29<span>]</span></a></sup></p>
<p>Regarding the screening of men, a cost-analysis study suggests that screening may be "cost-effective for men with a self-reported prior fracture beginning at age 65 years and for men 80 years and older with no prior fracture".<sup id="cite_ref-pmid17684185_29-0" class="reference"><a href="#cite_note-pmid17684185-29" title=""><span>[</span>30<span>]</span></a></sup> Also cost-effective is the screening of adult men from middle age on to detect any significant decrease in testosterone levels, say, below 300.</p>
<p><a name="Pathogenesis" id="Pathogenesis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=12" title="Edit section: Pathogenesis">edit</a>]</span> <span class="mw-headline">Pathogenesis</span></h2>
<p>The underlying mechanism in all cases of osteoporosis is an imbalance between <a href="/wiki/Bone_resorption" title="Bone resorption">bone resorption</a> and <a href="/wiki/Bone#Formation" title="Bone">bone formation</a>. In normal bone, there is constant <a href="/wiki/Matrix_(biology)" title="Matrix (biology)">matrix</a> remodeling of bone; up to 10% of all bone mass may be undergoing remodeling at any point in time. The process takes place in bone multicellular units (BMUs) as first described by Frost in 1963.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30" title=""><span>[</span>31<span>]</span></a></sup> Bone is resorbed by <a href="/wiki/Osteoclast" title="Osteoclast">osteoclast</a> cells (which derive from the <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a>), after which new bone is deposited by <a href="/wiki/Osteoblast" title="Osteoblast">osteoblast</a> cells. <sup id="cite_ref-Raisz_4-1" class="reference"><a href="#cite_note-Raisz-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p>The three main mechanisms by which osteoporosis develops are an inadequate <i>peak bone mass</i> (the skeleton develops insufficient mass and strength during growth), excessive bone resorption and inadequate formation of new bone during remodeling. An interplay of these three mechanisms underlies the development of fragile bone tissue.<sup id="cite_ref-Raisz_4-2" class="reference"><a href="#cite_note-Raisz-4" title=""><span>[</span>5<span>]</span></a></sup> Hormonal factors strongly determine the rate of bone resorption; lack of <a href="/wiki/Estrogen" title="Estrogen">estrogen</a> (e.g. as a result of menopause) increases bone resorption as well as decreasing the deposition of new bone that normally takes place in weight-bearing bones. The amount of estrogen needed to suppress this process is lower than that normally needed to stimulate the <a href="/wiki/Uterus" title="Uterus">uterus</a> and <a href="/wiki/Mammary_gland" title="Mammary gland">breast gland</a>. The α-form of the <a href="/wiki/Estrogen_receptor" title="Estrogen receptor">estrogen receptor</a> appears to be the most important in regulating bone turnover.<sup id="cite_ref-Raisz_4-3" class="reference"><a href="#cite_note-Raisz-4" title=""><span>[</span>5<span>]</span></a></sup> In addition to estrogen, <a href="/wiki/Calcium_metabolism" title="Calcium metabolism">calcium metabolism</a> plays a significant role in bone turnover, and deficiency of <a href="/wiki/Calcium_in_biology" title="Calcium in biology">calcium</a> and <a href="/wiki/Vitamin_D" title="Vitamin D">vitamin D</a> leads to impaired bone deposition; in addition, the <a href="/wiki/Parathyroid_gland" title="Parathyroid gland">parathyroid glands</a> react to low calcium levels by secreting <a href="/wiki/Parathyroid_hormone" title="Parathyroid hormone">parathyroid hormone</a> (parathormone, PTH), which increases bone resorption to ensure sufficient calcium in the blood. The role of <a href="/wiki/Calcitonin" title="Calcitonin">calcitonin</a>, a hormone generated by the <a href="/wiki/Thyroid" title="Thyroid">thyroid</a> that increases bone deposition, is less clear and probably not as significant as that of PTH.<sup id="cite_ref-Raisz_4-4" class="reference"><a href="#cite_note-Raisz-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p>The activation of osteoclasts is regulated by various molecular signals, of which <a href="/wiki/RANKL" title="RANKL">RANKL</a> (receptor activator for <a href="/wiki/NF-kB" title="NF-kB" class="mw-redirect">nuclear factor κB</a> ligand) is one of best studied. This molecule is produced by osteoblasts and other cells (e.g. <a href="/wiki/Lymphocyte" title="Lymphocyte">lymphocytes</a>), and stimulates <a href="/wiki/RANK" title="RANK">RANK</a> (receptor activator of nuclear factor κB). <a href="/wiki/Osteoprotegerin" title="Osteoprotegerin">Osteoprotegerin</a> (OPG) binds RANKL before it has an opportunity to bind to RANK, and hence suppresses its ability to increase bone resorption. RANKL, RANK and OPG are closely related to <a href="/wiki/Tumor_necrosis_factor" title="Tumor necrosis factor">tumor necrosis factor</a> and its receptors. The role of the <a href="/wiki/Wnt_signaling_pathway" title="Wnt signaling pathway"><i>wnt</i> signalling pathway</a> is recognized but less well understood. Local production of <a href="/wiki/Eicosanoid" title="Eicosanoid">eicosanoids</a> and <a href="/wiki/Interleukin" title="Interleukin">interleukins</a> is thought to participate in the regulation of bone turnover, and excess or reduced production of these mediators may underlie the development of osteoporosis.<sup id="cite_ref-Raisz_4-5" class="reference"><a href="#cite_note-Raisz-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<p><a href="/wiki/Trabecular_bone" title="Trabecular bone" class="mw-redirect">Trabecular bone</a> is the sponge-like bone in the ends of long bones and vertebrae. <a href="/wiki/Cortical_bone" title="Cortical bone">Cortical bone</a> is the hard outer shell of bones and the middle of long bones. Because osteoblasts and osteoclasts inhabit the surface of bones, trabecular bone is more active, more subject to bone turnover, to remodeling. Not only is bone density decreased, but the microarchitecture of bone is disrupted. The weaker spicules of trabecular bone break ("microcracks"), and are replaced by weaker bone. Common osteoporotic fracture sites, the wrist, the hip and the spine, have a relatively high trabecular bone to cortical bone ratio. These areas rely on trabecular bone for strength, and therefore the intense remodeling causes these areas to degenerate most when the remodeling is imbalanced.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since September 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p><a name="Treatment" id="Treatment"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=13" title="Edit section: Treatment">edit</a>]</span> <span class="mw-headline">Treatment</span></h2>
<p>There are several medications used to treat osteoporosis, depending on gender. Lifestyle changes are also an aspect of treatment.</p>
<p><a name="Medication_2" id="Medication_2"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=14" title="Edit section: Medication">edit</a>]</span> <span class="mw-headline">Medication</span></h3>
<p>Bisphosphonates are the main pharmacological measures for treatment. However, newer drugs have appeared in the 1990s, such as teriparatide and strontium ranelate.</p>
<dl>
<dt>Bisphosphonates</dt>
</dl>
<p>In confirmed osteoporosis, <a href="/wiki/Bisphosphonate" title="Bisphosphonate">bisphosphonate</a> drugs are the first-line treatment in women. The most often prescribed bisphosphonates are presently<sup class="plainlinks noprint asof-tag update" style="display:none;"><a href="http://en.wikipedia.org/w/index.php?title=Osteoporosis&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Osteoporosis&amp;action=edit" rel="nofollow">[update]</a></sup> <a href="/wiki/Sodium_alendronate" title="Sodium alendronate" class="mw-redirect">sodium alendronate</a> (Fosamax) 10&#160;mg a day or 70&#160;mg once a week, <a href="/wiki/Risedronate" title="Risedronate" class="mw-redirect">risedronate</a> (Actonel) 5&#160;mg a day or 35&#160;mg once a week and or <a href="/wiki/Ibandronate" title="Ibandronate" class="mw-redirect">ibandronate</a> (Boniva) once a month.</p>
<p>A 2007 manufacturer-supported study suggested that in patients who had suffered a low-impact hip fracture, annual infusion of 5&#160;mg <a href="/wiki/Zoledronate" title="Zoledronate" class="mw-redirect">zoledronic acid</a> reduced risk of any fracture by 35% (from 13.9 to 8.6%), vertebral fracture risk from 3.8% to 1.7% and non-vertebral fracture risk from 10.7% to 7.6%. This study also found a mortality benefit: after 1.9 years, 9.6% of the study group (as opposed to 13.3% of the control group) had died of any cause, indicating a mortality benefit of 28%.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31" title=""><span>[</span>32<span>]</span></a></sup></p>
<p>Oral bisphosphonates are relatively poorly absorbed, and must therefore be taken on an empty stomach, with no food or drink to follow for the next 30 minutes. They are associated with <a href="/wiki/Esophagitis" title="Esophagitis">esophagitis</a> and are therefore sometimes poorly tolerated; weekly or monthly administration (depending on the preparation) decreases likelihood of esophagitis, and is now standard. Although intermittent dosing with the intravenous formulations such as zolendronate avoids oral tolerance problems, these agents are implicated at higher rates in a rare but unpleasant mouth disease called <a href="/wiki/Osteonecrosis_of_the_jaw" title="Osteonecrosis of the jaw">osteonecrosis of the jaw</a>.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32" title=""><span>[</span>33<span>]</span></a></sup> For this reason, oral bisphosphonate therapy is probably to be preferred, and prescribing advice now recommends any remedial dental work to be carried out prior to commencing treatment.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33" title=""><span>[</span>34<span>]</span></a></sup></p>
<dl>
<dt>Teriparatide</dt>
</dl>
<p>Recently, <a href="/wiki/Teriparatide" title="Teriparatide">teriparatide</a> (Forteo, <a href="/wiki/Recombinant" title="Recombinant">recombinant</a> <a href="/wiki/Parathyroid_hormone" title="Parathyroid hormone">parathyroid hormone</a> residues 1–34) has been shown to be effective in osteoporosis. It acts like parathyroid hormone and stimulates osteoblasts, thus increasing their activity. It is used mostly for patients with established osteoporosis (who have already fractured), have particularly low BMD or several risk factors for fracture or cannot tolerate the oral bisphosphonates. It is given as a daily injection with the use of a pen-type injection device. Teriparatide is only licensed for treatment if bisphosphonates have failed or are contraindicated (however, this differs by country and is not required by the FDA in the USA. However, patients with previous radiation therapy, or Paget's disease, or young patients should avoid this medication).</p>
<dl>
<dt>Strontium ranelate</dt>
</dl>
<p>Oral <a href="/wiki/Strontium_ranelate" title="Strontium ranelate">strontium ranelate</a> is an alternative oral treatment, belonging to a class of drugs called "dual action bone agents" (DABAs) by its manufacturer. It has proven efficacy, especially in the prevention of vertebral fracture.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34" title=""><span>[</span>35<span>]</span></a></sup> In laboratory experiments, strontium ranelate was noted to stimulate the proliferation of osteoblasts, as well as inhibiting the proliferation of osteoclasts.</p>
<p>Strontium ranelate is taken as a 2&#160;g oral suspension daily, and is licenced for the treatment of osteoporosis to prevent vertebral and hip fracture. Strontium ranelate has side effect benefits over the bisphosphonates, as it does not cause any form of upper GI side effect, which is the most common cause for medication withdrawal in osteoporosis. In studies a small increase in the risk of <a href="/wiki/Venous_thromboembolism" title="Venous thromboembolism" class="mw-redirect">venous thromboembolism</a> was noted,<sup id="cite_ref-35" class="reference"><a href="#cite_note-35" title=""><span>[</span>36<span>]</span></a></sup> the cause for which has not been determined. This suggests it may be less suitable in patients at risk for thrombosis for different reasons. The uptake of (heavier) strontium in place of calcium into bone matrix results in a substantial and disproportionate increase in bone mineral density as measured on DXA scanning<sup id="cite_ref-36" class="reference"><a href="#cite_note-36" title=""><span>[</span>37<span>]</span></a></sup>, making further followup of bone density by this method harder to interpret for strontium treated patients. A correction algorithm has been devised.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37" title=""><span>[</span>38<span>]</span></a></sup></p>
<p>Although strontium ranelate is effective, it's not approved for use in the United States yet. However, strontium citrate is available in the U.S. from several well-known vitamin manufacturers. Most researchers believe that strontium is safe and effective no matter what form it's used. The ranelate form is simply a device invented by the Servier company of France so that they could patent their version of strontium.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since April 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p>Strontium, no matter what the form, must be water-soluble and ionized in the stomach acid. Strontium is then protein-bound for transport from the intestinal tract into the blood stream. Unlike drugs like <a href="/wiki/Sodium_alendronate" title="Sodium alendronate" class="mw-redirect">sodium alendronate</a> (Fosamax), strontium doesn't inhibit bone recycling and, in fact, may produce stronger bones. Studies have shown that after five years alendronate may even cause bone loss, while strontium continues to build bone during lifetime use.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since April 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p>Strontium must not be taken with food or calcium-containing preparations as calcium competes with strontium during uptake. However, it's essential that calcium, magnesium, and vitamin D in therapeutic amounts must be taken daily, but not at the same time as strontium. Strontium should be taken on an empty stomach at night.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since April 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<dl>
<dt>Hormone replacement</dt>
</dl>
<p><a href="/wiki/Estrogen_replacement_therapy" title="Estrogen replacement therapy" class="mw-redirect">Estrogen replacement therapy</a> remains a good treatment for prevention of osteoporosis but, at this time, is not recommended unless there are other indications for its use as well. There is uncertainty and controversy about whether estrogen should be recommended in women in the first decade after the menopause.</p>
<p>In hypogonadal men <a href="/wiki/Testosterone" title="Testosterone">testosterone</a> has been shown to give improvement in bone quantity and quality, but, as of 2008, there are no studies of the effects on fractures or in men with a normal testosterone level.<sup id="cite_ref-OsteoporosisMen_18-2" class="reference"><a href="#cite_note-OsteoporosisMen-18" title=""><span>[</span>19<span>]</span></a></sup></p>
<dl>
<dt>Selective estrogen receptor modulator (SERM)</dt>
</dl>
<p>SERMs are a class of medications that act on the estrogen receptors throughout the body in a selective manner. Normally, <a href="/wiki/Bone_mineral_density" title="Bone mineral density" class="mw-redirect">bone mineral density</a> (BMD) is tightly regulated by a balance between <a href="/wiki/Osteoblast" title="Osteoblast">osteoblast</a> and <a href="/wiki/Osteoclast" title="Osteoclast">osteoclast</a> activity in the trabecular bone. Estrogen has a major role in regulation of the bone formation-resorption equilibrium, as it stimulates osteoblast activity. Some SERMs such as <a href="/wiki/Raloxifene" title="Raloxifene">raloxifene</a>, act on the bone by slowing bone resorption by the osteoclasts.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38" title=""><span>[</span>39<span>]</span></a></sup> SERMs have been proved as effective in clinical trials.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39" title=""><span>[</span>40<span>]</span></a></sup><sup id="cite_ref-40" class="reference"><a href="#cite_note-40" title=""><span>[</span>41<span>]</span></a></sup></p>
<p><a name="Nutrition" id="Nutrition"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=15" title="Edit section: Nutrition">edit</a>]</span> <span class="mw-headline">Nutrition</span></h3>
<dl>
<dt>Calcium</dt>
</dl>
<p><a href="/wiki/Calcium" title="Calcium">Calcium</a> is required to support <a href="/wiki/Ossification" title="Ossification">bone growth</a>, <a href="/wiki/Bone_healing" title="Bone healing">bone healing</a> and maintain bone strength and is one aspect of treatment for osteoporosis. Recommendations for calcium intake vary depending country and age; for individuals at higher risk of osteoporosis (after fifty years of age) the amount recommended by <a href="/wiki/United_States" title="United States">US</a> health agencies is 1,200&#160;mg per day. Calcium supplements can be used to increase dietary intake, and absorption is optimized through taking in several small (500&#160;mg or less) <a href="/wiki/Dose_(pharmacology)" title="Dose (pharmacology)" class="mw-redirect">doses</a> throughout the day.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41" title=""><span>[</span>42<span>]</span></a></sup> The role of calcium in preventing and treating osteoporosis is unclear&#160;— some populations with extremely low calcium intake also have extremely low rates of bone fracture, and others with high rates of calcium intake through <a href="/wiki/Milk" title="Milk">milk</a> and milk products have higher rates of bone fracture. Other factors, such as protein, salt and vitamin D intake, exercise and exposure to sunlight, can all influence bone mineralization, making calcium intake one factor among many in the development of osteoporosis.<sup id="cite_ref-Harvard_42-0" class="reference"><a href="#cite_note-Harvard-42" title=""><span>[</span>43<span>]</span></a></sup> In the report of <a href="/wiki/WHO" title="WHO" class="mw-redirect">WHO</a> (World Health Organization) in 2007, because calcium is consumed by an acid load with food, it influences osteoporosis.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43" title=""><span>[</span>44<span>]</span></a></sup><sup id="cite_ref-44" class="reference"><a href="#cite_note-44" title=""><span>[</span>45<span>]</span></a></sup>.</p>
<p>A <a href="/wiki/Meta-analysis" title="Meta-analysis">meta-analysis</a> of <a href="/wiki/Randomized_controlled_trial" title="Randomized controlled trial">randomized controlled trials</a> involving calcium and calcium plus vitamin D supported the use of high levels of calcium (1,200&#160;mg or more) and vitamin D (800 IU or more), though outcomes varied depending on which measure was used to assess bone health (rates of fracture versus rates of bone loss).<sup id="cite_ref-pmid17720017_45-0" class="reference"><a href="#cite_note-pmid17720017-45" title=""><span>[</span>46<span>]</span></a></sup> The meta-analysis, along with another study, also supported much better outcomes for patients with high <a href="/wiki/Compliance_(medicine)" title="Compliance (medicine)">compliance</a> to the treatment protocol.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46" title=""><span>[</span>47<span>]</span></a></sup> In contrast, despite earlier reports in improved <a href="/wiki/High_density_lipoprotein" title="High density lipoprotein" class="mw-redirect">high density lipoprotein</a> (HDL, "good cholesterol") in calcium supplementation, a possible increase in the rate of <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> (heart attack) was found in a study in <a href="/wiki/New_Zealand" title="New Zealand">New Zealand</a> in which 1471 women participated. If confirmed, this would indicate that calcium supplementation in women otherwise at low risk of fracture may cause more harm than good.<sup id="cite_ref-pmid18198394_47-0" class="reference"><a href="#cite_note-pmid18198394-47" title=""><span>[</span>48<span>]</span></a></sup></p>
<dl>
<dt>Vitamin D</dt>
</dl>
<p>Some studies have shown that a high intake of <a href="/wiki/Vitamin_D" title="Vitamin D">vitamin D</a> reduces fractures in the elderly,<sup id="cite_ref-pmid17720017_45-1" class="reference"><a href="#cite_note-pmid17720017-45" title=""><span>[</span>46<span>]</span></a></sup><sup id="cite_ref-48" class="reference"><a href="#cite_note-48" title=""><span>[</span>49<span>]</span></a></sup> though the <a href="/wiki/Women%27s_Health_Initiative" title="Women's Health Initiative">Women's Health Initiative</a> found that though calcium plus vitamin D did increase bone density, it did not affect hip fracture but did increase formation of <a href="/wiki/Kidney_stone" title="Kidney stone">kidney stones</a>.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49" title=""><span>[</span>50<span>]</span></a></sup></p>
<p><a name="Exercise" id="Exercise"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=16" title="Edit section: Exercise">edit</a>]</span> <span class="mw-headline">Exercise</span></h3>
<p>Multiple studies have shown that aerobics, weight bearing, and resistance exercises can all maintain or increase BMD in postmenopausal women.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50" title=""><span>[</span>51<span>]</span></a></sup> Many researchers have attempted to pinpoint which types of exercise are most effective at improving BMD and other metrics of bone quality, however results have varied. One year of regular jumping exercises appears to increase the BMD and <a href="/wiki/Moment_of_inertia" title="Moment of inertia">moment of inertia</a> of the proximal <a href="/wiki/Tibia" title="Tibia">tibia</a><sup id="cite_ref-51" class="reference"><a href="#cite_note-51" title=""><span>[</span>52<span>]</span></a></sup> in normal postmenopausal women. Treadmill walking, gymnastic training, stepping, jumping, endurance, and strength exercises all resulted in significant increases of L2-L4 BMD in osteopenic postmenopausal women.<sup id="cite_ref-52" class="reference"><a href="#cite_note-52" title=""><span>[</span>53<span>]</span></a></sup><sup id="cite_ref-53" class="reference"><a href="#cite_note-53" title=""><span>[</span>54<span>]</span></a></sup><sup id="cite_ref-54" class="reference"><a href="#cite_note-54" title=""><span>[</span>55<span>]</span></a></sup> Strength training elicited improvements specifically in <a href="/wiki/Distal" title="Distal" class="mw-redirect">distal</a> <a href="/wiki/Radius_(bone)" title="Radius (bone)">radius</a> and hip BMD.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55" title=""><span>[</span>56<span>]</span></a></sup> Exercise combined with other pharmacological treatments such as <a href="/wiki/Hormone_replacement_therapy" title="Hormone replacement therapy">hormone replacement therapy</a> (HRT) has been shown to increases BMD more than HRT alone.<sup id="cite_ref-Villareal2003_56-0" class="reference"><a href="#cite_note-Villareal2003-56" title=""><span>[</span>57<span>]</span></a></sup></p>
<p>Additional benefits for osteoporotic patients other than BMD increase include improvements in balance, gait, and a reduction in risk of falls.<sup id="cite_ref-Mayo2005_57-0" class="reference"><a href="#cite_note-Mayo2005-57" title=""><span>[</span>58<span>]</span></a></sup></p>
<p><a name="Prognosis" id="Prognosis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=17" title="Edit section: Prognosis">edit</a>]</span> <span class="mw-headline">Prognosis</span></h2>
<table class="wikitable" align="right">
<caption>Hip fractures per 1000 patient-years<sup id="cite_ref-pmid17846439_58-0" class="reference"><a href="#cite_note-pmid17846439-58" title=""><span>[</span>59<span>]</span></a></sup></caption>
<tr>
<th>WHO category</th>
<th>Age 50-64</th>
<th>Age &gt; 64</th>
<th>Overall</th>
</tr>
<tr>
<td>Normal</td>
<td>5.3</td>
<td>9.4</td>
<td>6.6</td>
</tr>
<tr>
<td><a href="/wiki/Osteopenia" title="Osteopenia">Osteopenia</a></td>
<td>11.4</td>
<td>19.6</td>
<td>15.7</td>
</tr>
<tr>
<td>Osteoporosis</td>
<td>22.4</td>
<td>46.6</td>
<td>40.6</td>
</tr>
</table>
<p>Although osteoporosis patients have an increased mortality rate due to the complications of fracture, most patients die <i>with</i> the disease rather than <i>of</i> it.</p>
<p>Hip fractures can lead to decreased mobility and an additional risk of numerous complications (such as <a href="/wiki/Deep_venous_thrombosis" title="Deep venous thrombosis" class="mw-redirect">deep venous thrombosis</a> and/or <a href="/wiki/Pulmonary_embolism" title="Pulmonary embolism">pulmonary embolism</a>, <a href="/wiki/Pneumonia" title="Pneumonia">pneumonia</a>). The 6-month mortality rate following hip fracture is approximately 13.5%, and a substantial proportion (almost 13%) of people who have suffered a hip fracture need total assistance to mobilize after a hip fracture.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59" title=""><span>[</span>60<span>]</span></a></sup></p>
<p>Vertebral fractures, while having a smaller impact on mortality, can lead to severe chronic pain of neurogenic origin, which can be hard to control, as well as deformity. Though rare, multiple vertebral fractures can lead to such severe hunch back (<a href="/wiki/Kyphosis" title="Kyphosis">kyphosis</a>) that the resulting pressure on internal organs can impair one's ability to breathe.</p>
<p>Apart from risk of death and other complications, osteoporotic fractures are associated with a reduced health-related <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a>.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60" title=""><span>[</span>61<span>]</span></a></sup></p>
<p><a name="Epidemiology" id="Epidemiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=18" title="Edit section: Epidemiology">edit</a>]</span> <span class="mw-headline">Epidemiology</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:L1_2_vertebral_fracture.jpg" class="image" title="Lateral thoraco-lumbar spine X-ray demonstrating multiple wedge fractures"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/c/c3/L1_2_vertebral_fracture.jpg/180px-L1_2_vertebral_fracture.jpg" width="180" height="267" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:L1_2_vertebral_fracture.jpg" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Lateral thoraco-lumbar spine X-ray demonstrating multiple wedge fractures</div>
</div>
</div>
<p>It is estimated<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since September 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> that 1 in 3 women and 1 in 12 men over the age of 50 worldwide have osteoporosis. It is responsible for millions of fractures annually, mostly involving the lumbar <a href="/wiki/Vertebrae" title="Vertebrae" class="mw-redirect">vertebrae</a>, <a href="/wiki/Hip" title="Hip">hip</a>, and wrist. Fragility fractures of ribs are also common in men.</p>
<p><a name="Hip_fractures" id="Hip_fractures"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=19" title="Edit section: Hip fractures">edit</a>]</span> <span class="mw-headline">Hip fractures</span></h3>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Hip_fractures" title="Hip fractures" class="mw-redirect">hip fractures</a></div>
<p>Hip fractures are responsible for the most serious consequences of osteoporosis. In the United States, more than 250,000 hip fractures annually are attributible to osteoporosis.<sup id="cite_ref-RiggsEtAl2005_61-0" class="reference"><a href="#cite_note-RiggsEtAl2005-61" title=""><span>[</span>62<span>]</span></a></sup> It is estimated that a 50-year-old white woman has a 17.5% lifetime risk of fracture of the proximal <a href="/wiki/Femur" title="Femur">femur</a>. The incidence of hip fractures increases each decade from the sixth through the ninth for both women and men for all populations. The highest incidence is found among those men and women ages 80 or older.<sup id="cite_ref-Merkepid_62-0" class="reference"><a href="#cite_note-Merkepid-62" title=""><span>[</span>63<span>]</span></a></sup></p>
<p><a name="Vertebral_fractures" id="Vertebral_fractures"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=20" title="Edit section: Vertebral fractures">edit</a>]</span> <span class="mw-headline">Vertebral fractures</span></h3>
<p>Between 35-50% of all women over 50 had at least one vertebral fracture. In the United States, 700,000 vertebral fractures occur annually, but only about a third are recognized. In a series of 9704 of women aged 68.8 on average studied for 15 years, 324 had already suffered a vertebral fracture at entry into the study; 18.2% developed a vertebral fracture, but that risk rose to 41.4% in women who had a previous vertebral fracture.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63" title=""><span>[</span>64<span>]</span></a></sup></p>
<p><a name="Wrist" id="Wrist"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=21" title="Edit section: Wrist">edit</a>]</span> <span class="mw-headline">Wrist</span></h3>
<p>In the United States, 250,000 <a href="/wiki/Distal_radius_fracture" title="Distal radius fracture">wrist fractures</a> annually are attributable to Osteoporosis.<sup id="cite_ref-RiggsEtAl2005_61-1" class="reference"><a href="#cite_note-RiggsEtAl2005-61" title=""><span>[</span>62<span>]</span></a></sup> Wrist fractures are the third most common type of osteoporotic fractures. The lifetime risk of sustaining a Colles' fracture is about 16% for white women. By the time women reach age 70, about 20% have had at least one wrist fracture.<sup id="cite_ref-Merkepid_62-1" class="reference"><a href="#cite_note-Merkepid-62" title=""><span>[</span>63<span>]</span></a></sup></p>
<p><a name="Rib_Fractures" id="Rib_Fractures"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=22" title="Edit section: Rib Fractures">edit</a>]</span> <span class="mw-headline">Rib Fractures</span></h3>
<p>Fragility fractures of the ribs are common in men as young as age thirty-five on. These are often overlooked as signs of osteoporosis as these men are often physically active and suffer the fracture in the course of physical activity. An example would be as a result of falling while water skiing or jet skiing. However, a quick test of the individual's testosterone level following the diagnosis of the fracture will readily reveal whether that individual might be at risk.</p>
<p><a name="Prevention" id="Prevention"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=23" title="Edit section: Prevention">edit</a>]</span> <span class="mw-headline">Prevention</span></h2>
<p>Methods to prevent osteoporosis include changes of lifestyle. However, there are medications that can be used for prevention as well. As a different concept there are osteoporosis ortheses which help to prevent spine fractures and support the building up of muscles. <a href="/wiki/Fall_prevention" title="Fall prevention">Fall prevention</a> can help prevent osteoporosis complications.</p>
<p><a name="Lifestyle" id="Lifestyle"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=24" title="Edit section: Lifestyle">edit</a>]</span> <span class="mw-headline">Lifestyle</span></h3>
<p>Lifestyle prevention of osteoporosis is in many aspects inversions from potentially modifiable risk factors. As <a href="/wiki/Tobacco_smoking" title="Tobacco smoking">tobacco smoking</a> and unsafe <a href="/wiki/Alcoholic_beverage" title="Alcoholic beverage">alcohol</a> intake have been linked with osteoporosis, smoking cessation and moderation of alcohol intake are commonly recommended in the prevention of osteoporosis.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since February 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<dl>
<dt>Exercise</dt>
</dl>
<p>Achieving a higher peak bone mass through exercise and proper nutrition during adolescence is important for the prevention of osteoporosis. Exercise and nutrition throughout the rest of the life delays bone degeneration. Jogging, walking, or stair climbing at 70-90% of maximum effort three times per week, along with 1,500&#160;mg of calcium per day, increased bone density of the lumbar (lower) spine by 5% over 9 months. Individuals already diagnosed with osteopenia or osteoporosis should discuss their exercise program with their physician to avoid fractures.<sup id="cite_ref-pmid3259410_64-0" class="reference"><a href="#cite_note-pmid3259410-64" title=""><span>[</span>65<span>]</span></a></sup></p>
<dl>
<dt>Nutrition</dt>
</dl>
<p>Proper nutrition includes a diet sufficient in <a href="/wiki/Calcium" title="Calcium">calcium</a> and <a href="/wiki/Vitamin_D" title="Vitamin D">vitamin D</a>. Patients at risk for osteoporosis (e.g. <a href="/wiki/Steroid" title="Steroid">steroid</a> use) are generally treated with <a href="/wiki/Vitamin_D" title="Vitamin D">vitamin D</a> and calcium supplements and often with bisphosphonates. In <a href="/wiki/Kidney" title="Kidney">renal</a> disease, more active forms of Vitamin D such as paracalcitol or (1,25-dihydroxycholecalciferol or <a href="/wiki/Calcitriol" title="Calcitriol">calcitriol</a> which is the main biologically active form of vitamin D) is used, as the kidney cannot adequately generate calcitriol from calcidiol (25-hydroxycholecalciferol) which is the storage form of vitamin D.</p>
<p>High <a href="/wiki/Protein_in_nutrition" title="Protein in nutrition">dietary protein</a> intake increases calcium excretion in <a href="/wiki/Urine" title="Urine">urine</a> and has been linked to increased risk of fractures in research studies.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65" title=""><span>[</span>66<span>]</span></a></sup> Other investigations have shown that protein is required for calcium absorption, but that excessive protein consumption inhibits this process. No interventional trials have been performed on dietary protein in the prevention and treatment of osteoporosis.<sup id="cite_ref-pmid12936953_66-0" class="reference"><a href="#cite_note-pmid12936953-66" title=""><span>[</span>67<span>]</span></a></sup></p>
<p><a name="Medication_3" id="Medication_3"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=25" title="Edit section: Medication">edit</a>]</span> <span class="mw-headline">Medication</span></h3>
<p>Just as for treatment, <a href="/wiki/Bisphosphonate" title="Bisphosphonate">bisphosphonate</a> can be used in cases of very high risk. Other medicines prescribed for prevention of osteoporosis include <a href="/wiki/Raloxifene" title="Raloxifene">raloxifene</a>, a <a href="/wiki/Selective_estrogen_receptor_modulator" title="Selective estrogen receptor modulator">selective estrogen receptor modulator</a> (SERM).</p>
<p><a href="/wiki/Estrogen_replacement_therapy" title="Estrogen replacement therapy" class="mw-redirect">Estrogen replacement therapy</a> remains a good treatment for prevention of osteoporosis but, at this time, is not recommended unless there are other indications for its use as well. There is uncertainty and controversy about whether estrogen should be recommended in women in the first decade after the menopause.</p>
<p>In hypogonadal men <a href="/wiki/Testosterone" title="Testosterone">testosterone</a> has been shown to give improvement in bone quantity and quality, but, as of 2008, there are no studies of the effects on fractures or in men with a normal testosterone level.<sup id="cite_ref-OsteoporosisMen_18-3" class="reference"><a href="#cite_note-OsteoporosisMen-18" title=""><span>[</span>19<span>]</span></a></sup></p>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=26" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>The link between age-related reductions in bone density and fracture risk goes back at least to <a href="/wiki/Astley_Cooper" title="Astley Cooper">Astley Cooper</a>, and the term "osteoporosis" and recognition of its pathological appearance is generally attributed to the French pathologist <a href="/wiki/Jean_Lobstein" title="Jean Lobstein">Jean Lobstein</a>.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67" title=""><span>[</span>68<span>]</span></a></sup> The American endocrinologist <a href="/wiki/Fuller_Albright" title="Fuller Albright">Fuller Albright</a> linked osteoporosis with the postmenopausal state.<sup id="cite_ref-68" class="reference"><a href="#cite_note-68" title=""><span>[</span>69<span>]</span></a></sup> Bisphosponates, which revolutionized the treatment of osteoporosis, were discovered in the 1960s.<sup id="cite_ref-69" class="reference"><a href="#cite_note-69" title=""><span>[</span>70<span>]</span></a></sup></p>
<p><a name="Organisations" id="Organisations"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=27" title="Edit section: Organisations">edit</a>]</span> <span class="mw-headline">Organisations</span></h2>
<p>The <a href="/wiki/National_Osteoporosis_Society" title="National Osteoporosis Society">National Osteoporosis Society</a>, established in 1986, is the only <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a> <a href="/wiki/Charitable_organization" title="Charitable organization">charity</a> dedicated to improving the diagnosis, prevention and treatment of osteoporosis.<sup id="cite_ref-70" class="reference"><a href="#cite_note-70" title=""><span>[</span>71<span>]</span></a></sup><sup id="cite_ref-Medical_News_Today_71-0" class="reference"><a href="#cite_note-Medical_News_Today-71" title=""><span>[</span>72<span>]</span></a></sup></p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=28" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/Back_pain" title="Back pain">Back pain</a></li>
<li><a href="/wiki/Hip_protector" title="Hip protector">Hip protector</a></li>
<li><a href="/w/index.php?title=Osteoporosis_Orthesis&amp;action=edit&amp;redlink=1" class="new" title="Osteoporosis Orthesis (page does not exist)">Osteoporosis Orthesis</a></li>
<li><a href="/wiki/Dental_X-ray" title="Dental X-ray" class="mw-redirect">Dental X-ray</a></li>
<li><a href="/wiki/Osteopetrosis" title="Osteopetrosis">Osteopetrosis</a></li>
<li><a href="/wiki/Osteoimmunology" title="Osteoimmunology">Osteoimmunology</a></li>
<li><a href="/wiki/Ovariectomized_rat" title="Ovariectomized rat">Ovariectomized rat</a> model for osteoporosis research</li>
<li><a href="/wiki/Spaceflight_osteopenia" title="Spaceflight osteopenia">Spaceflight osteopenia</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=29" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-WHO1994-0">^ <a href="#cite_ref-WHO1994_0-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WHO1994_0-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-WHO1994_0-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFWHO1994">WHO (1994). "Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group". <i>World Health Organization technical report series</i> <b>843</b>: 1–129. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7941614" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7941614">PMID 7941614</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Assessment+of+fracture+risk+and+its+application+to+screening+for+postmenopausal+osteoporosis.+Report+of+a+WHO+Study+Group&amp;rft.jtitle=World+Health+Organization+technical+report+series&amp;rft.aulast=WHO&amp;rft.au=WHO&amp;rft.date=1994&amp;rft.volume=843&amp;rft.pages=1%E2%80%93129&amp;rft_id=info:pmid/7941614&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-1"><b><a href="#cite_ref-1" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKim_DH.2C_Vaccaro_AR2006">Kim DH, Vaccaro AR (2006). "Osteoporotic compression fractures of the spine; current options and considerations for treatment". <i>The spine journal&#160;: official journal of the North American Spine Society</i> <b>6</b> (5): 479–87. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.spinee.2006.04.013" class="external text" title="http://dx.doi.org/10.1016%2Fj.spinee.2006.04.013" rel="nofollow">10.1016/j.spinee.2006.04.013</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16934715" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16934715">PMID 16934715</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Osteoporotic+compression+fractures+of+the+spine%3B+current+options+and+considerations+for+treatment&amp;rft.jtitle=The+spine+journal+%3A+official+journal+of+the+North+American+Spine+Society&amp;rft.aulast=Kim+DH%2C+Vaccaro+AR&amp;rft.au=Kim+DH%2C+Vaccaro+AR&amp;rft.date=2006&amp;rft.volume=6&amp;rft.issue=5&amp;rft.pages=479%E2%80%9387&amp;rft_id=info:doi/10.1016%2Fj.spinee.2006.04.013&amp;rft_id=info:pmid/16934715&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-2"><b><a href="#cite_ref-2" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGanz_DA.2C_Bao_Y.2C_Shekelle_PG.2C_Rubenstein_LZ2007">Ganz DA, Bao Y, Shekelle PG, Rubenstein LZ (2007). "Will my patient fall?". <i>JAMA</i> <b>297</b> (1): 77–86. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.297.1.77" class="external text" title="http://dx.doi.org/10.1001%2Fjama.297.1.77" rel="nofollow">10.1001/jama.297.1.77</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17200478" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17200478">PMID 17200478</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Will+my+patient+fall%3F&amp;rft.jtitle=JAMA&amp;rft.aulast=Ganz+DA%2C+Bao+Y%2C+Shekelle+PG%2C+Rubenstein+LZ&amp;rft.au=Ganz+DA%2C+Bao+Y%2C+Shekelle+PG%2C+Rubenstein+LZ&amp;rft.date=2007&amp;rft.volume=297&amp;rft.issue=1&amp;rft.pages=77%E2%80%9386&amp;rft_id=info:doi/10.1001%2Fjama.297.1.77&amp;rft_id=info:pmid/17200478&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-3"><b><a href="#cite_ref-3" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMelton_LJ2003">Melton LJ (2003). "Epidemiology worldwide". <i>Endocrinol. Metab. Clin. North Am.</i> <b>32</b> (1): 1–13, v. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12699289" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12699289">PMID 12699289</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Epidemiology+worldwide&amp;rft.jtitle=Endocrinol.+Metab.+Clin.+North+Am.&amp;rft.aulast=Melton+LJ&amp;rft.au=Melton+LJ&amp;rft.date=2003&amp;rft.volume=32&amp;rft.issue=1&amp;rft.pages=1%E2%80%9313%2C+v&amp;rft_id=info:pmid/12699289&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Raisz-4">^ <a href="#cite_ref-Raisz_4-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Raisz_4-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Raisz_4-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Raisz_4-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Raisz_4-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Raisz_4-5" title=""><sup><i><b>f</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFRaisz_L2005">Raisz L (2005). "<a href="http://www.jci.org/cgi/content/full/115/12/3318" class="external text" title="http://www.jci.org/cgi/content/full/115/12/3318" rel="nofollow">Pathogenesis of osteoporosis: concepts, conflicts, and prospects.</a>". <i>J Clin Invest</i> <b>115</b> (12): 3318–25. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1172%2FJCI27071" class="external text" title="http://dx.doi.org/10.1172%2FJCI27071" rel="nofollow">10.1172/JCI27071</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16322775" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16322775">PMID 16322775</a><span class="printonly">. <a href="http://www.jci.org/cgi/content/full/115/12/3318" class="external free" title="http://www.jci.org/cgi/content/full/115/12/3318" rel="nofollow">http://www.jci.org/cgi/content/full/115/12/3318</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pathogenesis+of+osteoporosis%3A+concepts%2C+conflicts%2C+and+prospects.&amp;rft.jtitle=J+Clin+Invest&amp;rft.aulast=Raisz+L&amp;rft.au=Raisz+L&amp;rft.date=2005&amp;rft.volume=115&amp;rft.issue=12&amp;rft.pages=3318%E2%80%9325&amp;rft_id=info:doi/10.1172%2FJCI27071&amp;rft_id=info:pmid/16322775&amp;rft_id=http%3A%2F%2Fwww.jci.org%2Fcgi%2Fcontent%2Ffull%2F115%2F12%2F3318&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-5"><b><a href="#cite_ref-5" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFOjo_F.2C_Al_Snih_S.2C_Ray_LA.2C_Raji_MA.2C_Markides_KS2007">Ojo F, Al Snih S, Ray LA, Raji MA, Markides KS (2007). "History of fractures as predictor of subsequent hip and nonhip fractures among older Mexican Americans". <i>Journal of the National Medical Association</i> <b>99</b> (4): 412–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17444431" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17444431">PMID 17444431</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=History+of+fractures+as+predictor+of+subsequent+hip+and+nonhip+fractures+among+older+Mexican+Americans&amp;rft.jtitle=Journal+of+the+National+Medical+Association&amp;rft.aulast=Ojo+F%2C+Al+Snih+S%2C+Ray+LA%2C+Raji+MA%2C+Markides+KS&amp;rft.au=Ojo+F%2C+Al+Snih+S%2C+Ray+LA%2C+Raji+MA%2C+Markides+KS&amp;rft.date=2007&amp;rft.volume=99&amp;rft.issue=4&amp;rft.pages=412%E2%80%938&amp;rft_id=info:pmid/17444431&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-BMJosteoporosis-6">^ <a href="#cite_ref-BMJosteoporosis_6-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BMJosteoporosis_6-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFPoole_KE.2C_Compston_JE2006">Poole KE, Compston JE (December 2006). "Osteoporosis and its management". <i>BMJ</i> <b>333</b> (7581): 1251–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.39050.597350.47" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.39050.597350.47" rel="nofollow">10.1136/bmj.39050.597350.47</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17170416" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17170416">PMID 17170416</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Osteoporosis+and+its+management&amp;rft.jtitle=BMJ&amp;rft.aulast=Poole+KE%2C+Compston+JE&amp;rft.au=Poole+KE%2C+Compston+JE&amp;rft.date=December+2006&amp;rft.volume=333&amp;rft.issue=7581&amp;rft.pages=1251%E2%80%936&amp;rft_id=info:doi/10.1136%2Fbmj.39050.597350.47&amp;rft_id=info:pmid/17170416&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-7"><b><a href="#cite_ref-7" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBerg_KM.2C_Kunins_HV.2C_Jackson_JL_.27.27et_al.27.272008">Berg KM, Kunins HV, Jackson JL <i>et al</i> (2008). "Association between alcohol consumption and both osteoporotic fracture and bone density". <i>Am J Med</i> <b>121</b> (5): 406–18. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.amjmed.2007.12.012" class="external text" title="http://dx.doi.org/10.1016%2Fj.amjmed.2007.12.012" rel="nofollow">10.1016/j.amjmed.2007.12.012</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Association+between+alcohol+consumption+and+both+osteoporotic+fracture+and+bone+density&amp;rft.jtitle=Am+J+Med&amp;rft.aulast=Berg+KM%2C+Kunins+HV%2C+Jackson+JL+%27%27et+al%27%27&amp;rft.au=Berg+KM%2C+Kunins+HV%2C+Jackson+JL+%27%27et+al%27%27&amp;rft.date=2008&amp;rft.volume=121&amp;rft.issue=5&amp;rft.pages=406%E2%80%9318&amp;rft_id=info:doi/10.1016%2Fj.amjmed.2007.12.012&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-micronutrients-8">^ <a href="#cite_ref-micronutrients_8-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-micronutrients_8-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFNieves_JW2005">Nieves JW (2005). "<a href="http://www.ajcn.org/cgi/content/full/81/5/1232S" class="external text" title="http://www.ajcn.org/cgi/content/full/81/5/1232S" rel="nofollow">Osteoporosis: the role of micronutrients.</a>". <i>Am J Clin Nutr</i> <b>81</b> (5): 1232S–1239S. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15883457" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15883457">PMID 15883457</a><span class="printonly">. <a href="http://www.ajcn.org/cgi/content/full/81/5/1232S" class="external free" title="http://www.ajcn.org/cgi/content/full/81/5/1232S" rel="nofollow">http://www.ajcn.org/cgi/content/full/81/5/1232S</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Osteoporosis%3A+the+role+of+micronutrients.&amp;rft.jtitle=Am+J+Clin+Nutr&amp;rft.aulast=Nieves+JW&amp;rft.au=Nieves+JW&amp;rft.date=2005&amp;rft.volume=81&amp;rft.issue=5&amp;rft.pages=1232S%E2%80%931239S&amp;rft_id=info:pmid/15883457&amp;rft_id=http%3A%2F%2Fwww.ajcn.org%2Fcgi%2Fcontent%2Ffull%2F81%2F5%2F1232S&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-WHOcriteria-9">^ <a href="#cite_ref-WHOcriteria_9-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WHOcriteria_9-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-WHOcriteria_9-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-WHOcriteria_9-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-WHOcriteria_9-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-WHOcriteria_9-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-WHOcriteria_9-6" title=""><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-WHOcriteria_9-7" title=""><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-WHOcriteria_9-8" title=""><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-WHOcriteria_9-9" title=""><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-WHOcriteria_9-10" title=""><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-WHOcriteria_9-11" title=""><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-WHOcriteria_9-12" title=""><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-WHOcriteria_9-13" title=""><sup><i><b>n</b></i></sup></a> <cite style="font-style:normal" class="web" id="CITEREFWHO_Scientific_Group_on_the_Prevention_and_Management_of_Osteoporosis_.282000_:_Geneva.2C_Switzerland.292003">WHO Scientific Group on the Prevention and Management of Osteoporosis (2000&#160;: Geneva, Switzerland) (2003). <a href="http://whqlibdoc.who.int/trs/WHO_TRS_921.pdf" class="external text" title="http://whqlibdoc.who.int/trs/WHO_TRS_921.pdf" rel="nofollow">"Prevention and management of osteoporosis&#160;: report of a WHO scientific group"</a> (pdf)<span class="printonly">. <a href="http://whqlibdoc.who.int/trs/WHO_TRS_921.pdf" class="external free" title="http://whqlibdoc.who.int/trs/WHO_TRS_921.pdf" rel="nofollow">http://whqlibdoc.who.int/trs/WHO_TRS_921.pdf</a></span><span class="reference-accessdate">. Retrieved on 2007-05-31</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Prevention+and+management+of+osteoporosis+%3A+report+of+a+WHO+scientific+group&amp;rft.atitle=&amp;rft.aulast=WHO+Scientific+Group+on+the+Prevention+and+Management+of+Osteoporosis+%282000+%3A+Geneva%2C+Switzerland%29&amp;rft.au=WHO+Scientific+Group+on+the+Prevention+and+Management+of+Osteoporosis+%282000+%3A+Geneva%2C+Switzerland%29&amp;rft.date=2003&amp;rft_id=http%3A%2F%2Fwhqlibdoc.who.int%2Ftrs%2FWHO_TRS_921.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-10"><b><a href="#cite_ref-10" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWong_PK.2C_Christie_JJ.2C_Wark_JD2007">Wong PK, Christie JJ, Wark JD (2007). "<a href="http://www.clinsci.org/cs/113/0233/cs1130233.htm" class="external text" title="http://www.clinsci.org/cs/113/0233/cs1130233.htm" rel="nofollow">The effects of smoking on bone health</a>". <i>Clin. Sci.</i> <b>113</b> (5): 233–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1042%2FCS20060173" class="external text" title="http://dx.doi.org/10.1042%2FCS20060173" rel="nofollow">10.1042/CS20060173</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17663660" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17663660">PMID 17663660</a><span class="printonly">. <a href="http://www.clinsci.org/cs/113/0233/cs1130233.htm" class="external free" title="http://www.clinsci.org/cs/113/0233/cs1130233.htm" rel="nofollow">http://www.clinsci.org/cs/113/0233/cs1130233.htm</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+effects+of+smoking+on+bone+health&amp;rft.jtitle=Clin.+Sci.&amp;rft.aulast=Wong+PK%2C+Christie+JJ%2C+Wark+JD&amp;rft.au=Wong+PK%2C+Christie+JJ%2C+Wark+JD&amp;rft.date=2007&amp;rft.volume=113&amp;rft.issue=5&amp;rft.pages=233%E2%80%9341&amp;rft_id=info:doi/10.1042%2FCS20060173&amp;rft_id=info:pmid/17663660&amp;rft_id=http%3A%2F%2Fwww.clinsci.org%2Fcs%2F113%2F0233%2Fcs1130233.htm&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-11"><b><a href="#cite_ref-11" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFShapses_SA.2C_Riedt_CS2006">Shapses SA, Riedt CS (2006). "<a href="http://jn.nutrition.org/cgi/content/full/136/6/1453" class="external text" title="http://jn.nutrition.org/cgi/content/full/136/6/1453" rel="nofollow">Bone, body weight, and weight reduction: what are the concerns?</a>". <i>J. Nutr.</i> <b>136</b> (6): 1453–6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16702302" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16702302">PMID 16702302</a><span class="printonly">. <a href="http://jn.nutrition.org/cgi/content/full/136/6/1453" class="external free" title="http://jn.nutrition.org/cgi/content/full/136/6/1453" rel="nofollow">http://jn.nutrition.org/cgi/content/full/136/6/1453</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bone%2C+body+weight%2C+and+weight+reduction%3A+what+are+the+concerns%3F&amp;rft.jtitle=J.+Nutr.&amp;rft.aulast=Shapses+SA%2C+Riedt+CS&amp;rft.au=Shapses+SA%2C+Riedt+CS&amp;rft.date=2006&amp;rft.volume=136&amp;rft.issue=6&amp;rft.pages=1453%E2%80%936&amp;rft_id=info:pmid/16702302&amp;rft_id=http%3A%2F%2Fjn.nutrition.org%2Fcgi%2Fcontent%2Ffull%2F136%2F6%2F1453&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-12"><b><a href="#cite_ref-12" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFStaessen_J.2C_Roels_H.2C_Emelianov_D.2C_Kuznetsova_T.2C_Thijs_L.2C_Vangronsveld_J.2C_Fagard_R1999">Staessen J, Roels H, Emelianov D, Kuznetsova T, Thijs L, Vangronsveld J, Fagard R (Apr 3 1999). "Environmental exposure to cadmium, forearm bone density, and risk of fractures: prospective population study. Public Health and Environmental Exposure to Cadmium (PheeCad) Study Group.". <i>Lancet</i> <b>353</b> (9159): 1140–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2898%2909356-8" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2898%2909356-8" rel="nofollow">10.1016/S0140-6736(98)09356-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10209978" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10209978">PMID 10209978</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Environmental+exposure+to+cadmium%2C+forearm+bone+density%2C+and+risk+of+fractures%3A+prospective+population+study.+Public+Health+and+Environmental+Exposure+to+Cadmium+%28PheeCad%29+Study+Group.&amp;rft.jtitle=Lancet&amp;rft.aulast=Staessen+J%2C+Roels+H%2C+Emelianov+D%2C+Kuznetsova+T%2C+Thijs+L%2C+Vangronsveld+J%2C+Fagard+R&amp;rft.au=Staessen+J%2C+Roels+H%2C+Emelianov+D%2C+Kuznetsova+T%2C+Thijs+L%2C+Vangronsveld+J%2C+Fagard+R&amp;rft.date=Apr+3+1999&amp;rft.volume=353&amp;rft.issue=9159&amp;rft.pages=1140%E2%80%934&amp;rft_id=info:doi/10.1016%2FS0140-6736%2898%2909356-8&amp;rft_id=info:pmid/10209978&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-13"><b><a href="#cite_ref-13" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTucker_KL.2C_Morita_K.2C_Qiao_N.2C_Hannan_MT.2C_Cupples_LA.2C_Kiel_DP2006">Tucker KL, Morita K, Qiao N, Hannan MT, Cupples LA, Kiel DP (2006). "Colas, but not other carbonated beverages, are associated with low bone mineral density in older women: The Framingham Osteoporosis Study". <i>Am. J. Clin. Nutr.</i> <b>84</b> (4): 936–42. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17023723" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17023723">PMID 17023723</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Colas%2C+but+not+other+carbonated+beverages%2C+are+associated+with+low+bone+mineral+density+in+older+women%3A+The+Framingham+Osteoporosis+Study&amp;rft.jtitle=Am.+J.+Clin.+Nutr.&amp;rft.aulast=Tucker+KL%2C+Morita+K%2C+Qiao+N%2C+Hannan+MT%2C+Cupples+LA%2C+Kiel+DP&amp;rft.au=Tucker+KL%2C+Morita+K%2C+Qiao+N%2C+Hannan+MT%2C+Cupples+LA%2C+Kiel+DP&amp;rft.date=2006&amp;rft.volume=84&amp;rft.issue=4&amp;rft.pages=936%E2%80%9342&amp;rft_id=info:pmid/17023723&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> <cite style="font-style:normal" class="">"Soft drinks in schools". <i>Pediatrics</i> <b>113</b> (1 Pt 1): 152–4. 2004. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14702469" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14702469">PMID 14702469</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Soft+drinks+in+schools&amp;rft.jtitle=Pediatrics&amp;rft.date=2004&amp;rft.volume=113&amp;rft.issue=1+Pt+1&amp;rft.pages=152%E2%80%934&amp;rft_id=info:pmid/14702469&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-15"><b><a href="#cite_ref-15" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWaugh_EJ.2C_Lam_M-A.2C_Hawker_GA.2C_.27.27et_al..27.272009">Waugh EJ, Lam M-A, Hawker GA, <i>et al.</i> (2009). <i>Risk factors for low bone mass in healthy 40–60 year old women: A systematic review of the literature</i>. <b>20</b>. p. 1–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00198-008-0643-x" class="external text" title="http://dx.doi.org/10.1007%2Fs00198-008-0643-x" rel="nofollow">10.1007/s00198-008-0643-x</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Risk+factors+for+low+bone+mass+in+healthy+40%26ndash%3B60+year+old+women%3A+A+systematic+review+of+the+literature&amp;rft.aulast=Waugh+EJ%2C+Lam+M-A%2C+Hawker+GA%2C+%27%27et+al.%27%27&amp;rft.au=Waugh+EJ%2C+Lam+M-A%2C+Hawker+GA%2C+%27%27et+al.%27%27&amp;rft.date=2009&amp;rft.volume=20&amp;rft.issue=1&amp;rft.pages=p.+1%26ndash%3B21&amp;rft_id=info:doi/10.1007%2Fs00198-008-0643-x&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-ICSI-16">^ <a href="#cite_ref-ICSI_16-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ICSI_16-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-ICSI_16-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-ICSI_16-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-ICSI_16-4" title=""><sup><i><b>e</b></i></sup></a> <cite style="font-style:normal" class="web" id="CITEREFSimonelli.2C_C_.27.27et_al.27.272006">Simonelli, C <i>et al</i> (July 2006). <a href="http://www.icsi.org/osteoporosis/diagnosis_and_treatment_of_osteoporosis__3.html" class="external text" title="http://www.icsi.org/osteoporosis/diagnosis_and_treatment_of_osteoporosis__3.html" rel="nofollow">"ICSI Health Care Guideline: Diagnosis and Treatment of Osteoporosis, 5th edition"</a> (PDF). Institute for Clinical Systems Improvement<span class="printonly">. <a href="http://www.icsi.org/osteoporosis/diagnosis_and_treatment_of_osteoporosis__3.html" class="external free" title="http://www.icsi.org/osteoporosis/diagnosis_and_treatment_of_osteoporosis__3.html" rel="nofollow">http://www.icsi.org/osteoporosis/diagnosis_and_treatment_of_osteoporosis__3.html</a></span><span class="reference-accessdate">. Retrieved on 2008-04-08</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=ICSI+Health+Care+Guideline%3A+Diagnosis+and+Treatment+of+Osteoporosis%2C+5th+edition&amp;rft.atitle=&amp;rft.aulast=Simonelli%2C+C+%27%27et+al%27%27&amp;rft.au=Simonelli%2C+C+%27%27et+al%27%27&amp;rft.date=July+2006&amp;rft.pub=Institute+for+Clinical+Systems+Improvement&amp;rft_id=http%3A%2F%2Fwww.icsi.org%2Fosteoporosis%2Fdiagnosis_and_treatment_of_osteoporosis__3.html&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-medscapeosteoporosis-17">^ <a href="#cite_ref-medscapeosteoporosis_17-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-medscapeosteoporosis_17-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-medscapeosteoporosis_17-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-medscapeosteoporosis_17-3" title=""><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-medscapeosteoporosis_17-4" title=""><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-medscapeosteoporosis_17-5" title=""><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-medscapeosteoporosis_17-6" title=""><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-medscapeosteoporosis_17-7" title=""><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-medscapeosteoporosis_17-8" title=""><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-medscapeosteoporosis_17-9" title=""><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-medscapeosteoporosis_17-10" title=""><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-medscapeosteoporosis_17-11" title=""><sup><i><b>l</b></i></sup></a> <cite style="font-style:normal" class="web" id="CITEREFKohlmeier1998">Kohlmeier, Lynn Kohlmeier (1998). <a href="http://www.medscape.com/viewarticle/427342" class="external text" title="http://www.medscape.com/viewarticle/427342" rel="nofollow">"Osteoporosis - Risk Factors, Screening, and Treatment"</a>. Medscape Portals<span class="printonly">. <a href="http://www.medscape.com/viewarticle/427342" class="external free" title="http://www.medscape.com/viewarticle/427342" rel="nofollow">http://www.medscape.com/viewarticle/427342</a></span><span class="reference-accessdate">. Retrieved on 2008-05-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Osteoporosis+-+Risk+Factors%2C+Screening%2C+and+Treatment&amp;rft.atitle=&amp;rft.aulast=Kohlmeier&amp;rft.aufirst=Lynn+Kohlmeier&amp;rft.au=Kohlmeier%2C+Lynn+Kohlmeier&amp;rft.date=1998&amp;rft.pub=Medscape+Portals&amp;rft_id=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F427342&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-OsteoporosisMen-18">^ <a href="#cite_ref-OsteoporosisMen_18-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-OsteoporosisMen_18-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-OsteoporosisMen_18-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-OsteoporosisMen_18-3" title=""><sup><i><b>d</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFEbeling_PR2008">Ebeling PR (2008). "Clinical practice. Osteoporosis in men". <i>N Engl J Med</i> <b>358</b> (14): 1474–82. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMcp0707217" class="external text" title="http://dx.doi.org/10.1056%2FNEJMcp0707217" rel="nofollow">10.1056/NEJMcp0707217</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18385499" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18385499">PMID 18385499</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Clinical+practice.+Osteoporosis+in+men&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Ebeling+PR&amp;rft.au=Ebeling+PR&amp;rft.date=2008&amp;rft.volume=358&amp;rft.issue=14&amp;rft.pages=1474%E2%80%9382&amp;rft_id=info:doi/10.1056%2FNEJMcp0707217&amp;rft_id=info:pmid/18385499&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-19"><b><a href="#cite_ref-19" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFBone_and_Tooth_Society_of_Great_Britain.2C_.5B.5BNational_Osteoporosis_Society.5D.5D.2C_Royal_College_of_Physicians2003">Bone and Tooth Society of Great Britain, <a href="/wiki/National_Osteoporosis_Society" title="National Osteoporosis Society">National Osteoporosis Society</a>, Royal College of Physicians (2003). <i><a href="http://www.rcplondon.ac.uk/pubs/contents/966c62dd-8011-4f65-a61d-dd0c7fe4fa4b.pdf" class="external text" title="http://www.rcplondon.ac.uk/pubs/contents/966c62dd-8011-4f65-a61d-dd0c7fe4fa4b.pdf" rel="nofollow">Glucocorticoid-induced Osteoporosis</a></i>. London, UK: Royal College of Physicians of London. <a href="/wiki/Special:BookSources/1860161731" class="internal">ISBN 1-860-16173-1</a><span class="printonly">. <a href="http://www.rcplondon.ac.uk/pubs/contents/966c62dd-8011-4f65-a61d-dd0c7fe4fa4b.pdf" class="external free" title="http://www.rcplondon.ac.uk/pubs/contents/966c62dd-8011-4f65-a61d-dd0c7fe4fa4b.pdf" rel="nofollow">http://www.rcplondon.ac.uk/pubs/contents/966c62dd-8011-4f65-a61d-dd0c7fe4fa4b.pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Glucocorticoid-induced+Osteoporosis&amp;rft.aulast=Bone+and+Tooth+Society+of+Great+Britain%2C+%5B%5BNational+Osteoporosis+Society%5D%5D%2C+Royal+College+of+Physicians&amp;rft.au=Bone+and+Tooth+Society+of+Great+Britain%2C+%5B%5BNational+Osteoporosis+Society%5D%5D%2C+Royal+College+of+Physicians&amp;rft.date=2003&amp;rft.place=London%2C+UK&amp;rft.pub=Royal+College+of+Physicians+of+London&amp;rft.isbn=1-860-16173-1&amp;rft_id=http%3A%2F%2Fwww.rcplondon.ac.uk%2Fpubs%2Fcontents%2F966c62dd-8011-4f65-a61d-dd0c7fe4fa4b.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-GIOP-20"><b><a href="#cite_ref-GIOP_20-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGourlay_M.2C_Franceschini_N.2C_Sheyn_Y2007">Gourlay M, Franceschini N, Sheyn Y (2007). "Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures". <i>Clin Rheumatol</i> <b>26</b> (2): 144–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs10067-006-0315-1" class="external text" title="http://dx.doi.org/10.1007%2Fs10067-006-0315-1" rel="nofollow">10.1007/s10067-006-0315-1</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16670825" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16670825">PMID 16670825</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prevention+and+treatment+strategies+for+glucocorticoid-induced+osteoporotic+fractures&amp;rft.jtitle=Clin+Rheumatol&amp;rft.aulast=Gourlay+M%2C+Franceschini+N%2C+Sheyn+Y&amp;rft.au=Gourlay+M%2C+Franceschini+N%2C+Sheyn+Y&amp;rft.date=2007&amp;rft.volume=26&amp;rft.issue=2&amp;rft.pages=144%E2%80%9353&amp;rft_id=info:doi/10.1007%2Fs10067-006-0315-1&amp;rft_id=info:pmid/16670825&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-21"><b><a href="#cite_ref-21" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPetty_SJ.2C_O.27Brien_TJ.2C_Wark_JD2007">Petty SJ, O'Brien TJ, Wark JD (2007). "Anti-epileptic medication and bone health". <i>Osteoporosis international</i> <b>18</b> (2): 129–42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs00198-006-0185-z" class="external text" title="http://dx.doi.org/10.1007%2Fs00198-006-0185-z" rel="nofollow">10.1007/s00198-006-0185-z</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17091219" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17091219">PMID 17091219</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Anti-epileptic+medication+and+bone+health&amp;rft.jtitle=Osteoporosis+international&amp;rft.aulast=Petty+SJ%2C+O%27Brien+TJ%2C+Wark+JD&amp;rft.au=Petty+SJ%2C+O%27Brien+TJ%2C+Wark+JD&amp;rft.date=2007&amp;rft.volume=18&amp;rft.issue=2&amp;rft.pages=129%E2%80%9342&amp;rft_id=info:doi/10.1007%2Fs00198-006-0185-z&amp;rft_id=info:pmid/17091219&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-22"><b><a href="#cite_ref-22" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRuiz-Irastorza_G.2C_Khamashta_MA.2C_Hughes_GR2002">Ruiz-Irastorza G, Khamashta MA, Hughes GR (2002). "Heparin and osteoporosis during pregnancy: 2002 update". <i>Lupus</i> <b>11</b> (10): 680–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1191%2F0961203302lu262oa" class="external text" title="http://dx.doi.org/10.1191%2F0961203302lu262oa" rel="nofollow">10.1191/0961203302lu262oa</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12413068" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12413068">PMID 12413068</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Heparin+and+osteoporosis+during+pregnancy%3A+2002+update&amp;rft.jtitle=Lupus&amp;rft.aulast=Ruiz-Irastorza+G%2C+Khamashta+MA%2C+Hughes+GR&amp;rft.au=Ruiz-Irastorza+G%2C+Khamashta+MA%2C+Hughes+GR&amp;rft.date=2002&amp;rft.volume=11&amp;rft.issue=10&amp;rft.pages=680%E2%80%932&amp;rft_id=info:doi/10.1191%2F0961203302lu262oa&amp;rft_id=info:pmid/12413068&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-23"><b><a href="#cite_ref-23" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGage_BF.2C_Birman-Deych_E.2C_Radford_MJ.2C_Nilasena_DS.2C_Binder_EF2006">Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF (2006). "<a href="http://archinte.ama-assn.org/cgi/content/full/166/2/241" class="external text" title="http://archinte.ama-assn.org/cgi/content/full/166/2/241" rel="nofollow">Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2</a>". <i>Arch. Intern. Med.</i> <b>166</b> (2): 241–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchinte.166.2.241" class="external text" title="http://dx.doi.org/10.1001%2Farchinte.166.2.241" rel="nofollow">10.1001/archinte.166.2.241</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16432096" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16432096">PMID 16432096</a><span class="printonly">. <a href="http://archinte.ama-assn.org/cgi/content/full/166/2/241" class="external free" title="http://archinte.ama-assn.org/cgi/content/full/166/2/241" rel="nofollow">http://archinte.ama-assn.org/cgi/content/full/166/2/241</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Risk+of+osteoporotic+fracture+in+elderly+patients+taking+warfarin%3A+results+from+the+National+Registry+of+Atrial+Fibrillation+2&amp;rft.jtitle=Arch.+Intern.+Med.&amp;rft.aulast=Gage+BF%2C+Birman-Deych+E%2C+Radford+MJ%2C+Nilasena+DS%2C+Binder+EF&amp;rft.au=Gage+BF%2C+Birman-Deych+E%2C+Radford+MJ%2C+Nilasena+DS%2C+Binder+EF&amp;rft.date=2006&amp;rft.volume=166&amp;rft.issue=2&amp;rft.pages=241%E2%80%936&amp;rft_id=info:doi/10.1001%2Farchinte.166.2.241&amp;rft_id=info:pmid/16432096&amp;rft_id=http%3A%2F%2Farchinte.ama-assn.org%2Fcgi%2Fcontent%2Ffull%2F166%2F2%2F241&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-24"><b><a href="#cite_ref-24" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFYang_YX.2C_Lewis_JD.2C_Epstein_S.2C_Metz_DC2006">Yang YX, Lewis JD, Epstein S, Metz DC (2006). "Long-term proton pump inhibitor therapy and risk of hip fracture". <i>JAMA</i> <b>296</b>: 2947–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.296.24.2947" class="external text" title="http://dx.doi.org/10.1001%2Fjama.296.24.2947" rel="nofollow">10.1001/jama.296.24.2947</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17190895" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17190895">PMID 17190895</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Long-term+proton+pump+inhibitor+therapy+and+risk+of+hip+fracture&amp;rft.jtitle=JAMA&amp;rft.aulast=Yang+YX%2C+Lewis+JD%2C+Epstein+S%2C+Metz+DC&amp;rft.au=Yang+YX%2C+Lewis+JD%2C+Epstein+S%2C+Metz+DC&amp;rft.date=2006&amp;rft.volume=296&amp;rft.pages=2947%E2%80%9353&amp;rft_id=info:doi/10.1001%2Fjama.296.24.2947&amp;rft_id=info:pmid/17190895&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-25"><b><a href="#cite_ref-25" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMurphy_CE.2C_Rodgers_PT2007">Murphy CE, Rodgers PT (2007). "Effects of thiazolidinediones on bone loss and fracture". <i>Ann Pharmacother</i> <b>41</b> (12): 2014–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1345%2Faph.1K286" class="external text" title="http://dx.doi.org/10.1345%2Faph.1K286" rel="nofollow">10.1345/aph.1K286</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17940125" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17940125">PMID 17940125</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+thiazolidinediones+on+bone+loss+and+fracture&amp;rft.jtitle=Ann+Pharmacother&amp;rft.aulast=Murphy+CE%2C+Rodgers+PT&amp;rft.au=Murphy+CE%2C+Rodgers+PT&amp;rft.date=2007&amp;rft.volume=41&amp;rft.issue=12&amp;rft.pages=2014%E2%80%938&amp;rft_id=info:doi/10.1345%2Faph.1K286&amp;rft_id=info:pmid/17940125&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid14742881-26"><b><a href="#cite_ref-pmid14742881_26-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLeib_ES.2C_Lewiecki_EM.2C_Binkley_N.2C_Hamdy_RC2004">Leib ES, Lewiecki EM, Binkley N, Hamdy RC (2004). "Official positions of the International Society for Clinical Densitometry". <i>J Clin Densitom</i> <b>7</b> (1): 1799. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1385%2FJCD%3A7%3A1%3A1" class="external text" title="http://dx.doi.org/10.1385%2FJCD%3A7%3A1%3A1" rel="nofollow">10.1385/JCD:7:1:1</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14742881" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14742881">PMID 14742881</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Official+positions+of+the+International+Society+for+Clinical+Densitometry&amp;rft.jtitle=J+Clin+Densitom&amp;rft.aulast=Leib+ES%2C+Lewiecki+EM%2C+Binkley+N%2C+Hamdy+RC&amp;rft.au=Leib+ES%2C+Lewiecki+EM%2C+Binkley+N%2C+Hamdy+RC&amp;rft.date=2004&amp;rft.volume=7&amp;rft.issue=1&amp;rft.pages=1799&amp;rft_id=info:doi/10.1385%2FJCD%3A7%3A1%3A1&amp;rft_id=info:pmid/14742881&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span> quoted in: <a href="http://www.guideline.gov/summary/summary.aspx?ss=15&amp;doc_id=6567&amp;nbr=4129" class="external text" title="http://www.guideline.gov/summary/summary.aspx?ss=15&amp;doc_id=6567&amp;nbr=4129" rel="nofollow">"Diagnosis of osteoporosis in men, premenopausal women, and children"</a></li>
<li id="cite_note-pmid12230355-27"><b><a href="#cite_ref-pmid12230355_27-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFU.S._Preventive_Services_Task_Force2002">U.S. Preventive Services Task Force (2002). "Screening for osteoporosis in postmenopausal women: recommendations and rationale". <i>Ann. Intern. Med.</i> <b>137</b> (6): 526–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12230355" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12230355">PMID 12230355</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Screening+for+osteoporosis+in+postmenopausal+women%3A+recommendations+and+rationale&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.aulast=U.S.+Preventive+Services+Task+Force&amp;rft.au=U.S.+Preventive+Services+Task+Force&amp;rft.date=2002&amp;rft.volume=137&amp;rft.issue=6&amp;rft.pages=526%E2%80%938&amp;rft_id=info:pmid/12230355&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17552058-28"><b><a href="#cite_ref-pmid17552058_28-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMart.C3.ADnez-Aguil.C3.A0_D.2C_G.C3.B3mez-Vaquero_C.2C_Rozadilla_A.2C_Romera_M.2C_Narv.C3.A1ez_J.2C_Nolla_JM2007">Martínez-Aguilà D, Gómez-Vaquero C, Rozadilla A, Romera M, Narváez J, Nolla JM (2007). "Decision rules for selecting women for bone mineral density testing: application in postmenopausal women referred to a bone densitometry unit". <i>J. Rheumatol.</i> <b>34</b> (6): 1307–12. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17552058" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17552058">PMID 17552058</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Decision+rules+for+selecting+women+for+bone+mineral+density+testing%3A+application+in+postmenopausal+women+referred+to+a+bone+densitometry+unit&amp;rft.jtitle=J.+Rheumatol.&amp;rft.aulast=Mart%C3%ADnez-Aguil%C3%A0+D%2C+G%C3%B3mez-Vaquero+C%2C+Rozadilla+A%2C+Romera+M%2C+Narv%C3%A1ez+J%2C+Nolla+JM&amp;rft.au=Mart%C3%ADnez-Aguil%C3%A0+D%2C+G%C3%B3mez-Vaquero+C%2C+Rozadilla+A%2C+Romera+M%2C+Narv%C3%A1ez+J%2C+Nolla+JM&amp;rft.date=2007&amp;rft.volume=34&amp;rft.issue=6&amp;rft.pages=1307%E2%80%9312&amp;rft_id=info:pmid/17552058&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17684185-29"><b><a href="#cite_ref-pmid17684185_29-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSchousboe_JT.2C_Taylor_BC.2C_Fink_HA.2C_.27.27et_al.27.272007">Schousboe JT, Taylor BC, Fink HA, <i>et al</i> (2007). "Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men". <i>JAMA</i> <b>298</b> (6): 629–37. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.298.6.629" class="external text" title="http://dx.doi.org/10.1001%2Fjama.298.6.629" rel="nofollow">10.1001/jama.298.6.629</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17684185" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17684185">PMID 17684185</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cost-effectiveness+of+bone+densitometry+followed+by+treatment+of+osteoporosis+in+older+men&amp;rft.jtitle=JAMA&amp;rft.aulast=Schousboe+JT%2C+Taylor+BC%2C+Fink+HA%2C+%27%27et+al%27%27&amp;rft.au=Schousboe+JT%2C+Taylor+BC%2C+Fink+HA%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=298&amp;rft.issue=6&amp;rft.pages=629%E2%80%9337&amp;rft_id=info:doi/10.1001%2Fjama.298.6.629&amp;rft_id=info:pmid/17684185&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-30"><b><a href="#cite_ref-30" title="">^</a></b> Frost HM, Thomas CC. Bone Remodeling Dynamics. Springfield, IL: 1963.</li>
<li id="cite_note-31"><b><a href="#cite_ref-31" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLyles_KW.2C_Col.C3.B3n-Emeric_CS.2C_Magaziner_JS.2C_.27.27et_al.27.272007">Lyles KW, Colón-Emeric CS, Magaziner JS, <i>et al</i> (2007). "Zoledronic acid and clinical fractures and mortality after hip fracture". <i>N Engl J Med</i> <b>357</b>: published online <a href="/w/index.php?title=2007%E2%80%9309%E2%80%9317&amp;action=edit&amp;redlink=1" class="new" title="2007–09–17 (page does not exist)">2007–09–17</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa074941" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa074941" rel="nofollow">10.1056/NEJMoa074941</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17878149" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17878149">PMID 17878149</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Zoledronic+acid+and+clinical+fractures+and+mortality+after+hip+fracture&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Lyles+KW%2C+Col%C3%B3n-Emeric+CS%2C+Magaziner+JS%2C+%27%27et+al%27%27&amp;rft.au=Lyles+KW%2C+Col%C3%B3n-Emeric+CS%2C+Magaziner+JS%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=357&amp;rft.pages=published+online+%5B%5B2007%E2%80%9309%E2%80%9317%5D%5D&amp;rft_id=info:doi/10.1056%2FNEJMoa074941&amp;rft_id=info:pmid/17878149&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-32"><b><a href="#cite_ref-32" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPurcell.2C_P._Boyd.2C_I2005">Purcell, P. Boyd, I (2005). "Bisphosphonates and osteonecrosis of the jaw". <i>Medical Journal of Australia</i> <b>182</b> (8): 417–418.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bisphosphonates+and+osteonecrosis+of+the+jaw&amp;rft.jtitle=Medical+Journal+of+Australia&amp;rft.aulast=Purcell%2C+P.+Boyd%2C+I&amp;rft.au=Purcell%2C+P.+Boyd%2C+I&amp;rft.date=2005&amp;rft.volume=182&amp;rft.issue=8&amp;rft.pages=417%E2%80%93418&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-33"><b><a href="#cite_ref-33" title="">^</a></b> <cite style="font-style:normal" class="book">"6.6.2 Bisphosphonates". <i><a href="/wiki/British_National_Formulary" title="British National Formulary">British National Formulary</a></i> (54 ed.). <a href="/wiki/British_Medical_Association" title="British Medical Association">British Medical Association</a> and <a href="/wiki/Royal_Pharmaceutical_Society_of_Great_Britain" title="Royal Pharmaceutical Society of Great Britain">Royal Pharmaceutical Society of Great Britain</a>. September 2007. pp.&#160;p403.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=6.6.2+Bisphosphonates&amp;rft.atitle=%5B%5BBritish+National+Formulary%5D%5D&amp;rft.date=September+2007&amp;rft.pages=pp.%26nbsp%3Bp403&amp;rft.edition=54&amp;rft.pub=%5B%5BBritish+Medical+Association%5D%5D+and+%5B%5BRoyal+Pharmaceutical+Society+of+Great+Britain%5D%5D&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-34"><b><a href="#cite_ref-34" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMeunier_PJ.2C_Roux_C.2C_Seeman_E.2C_.27.27et_al.27.272004">Meunier PJ, Roux C, Seeman E, <i>et al</i> (2004). "The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis". <i>N. Engl. J. Med.</i> <b>350</b> (5): 459–68. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa022436" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa022436" rel="nofollow">10.1056/NEJMoa022436</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14749454" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14749454">PMID 14749454</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+effects+of+strontium+ranelate+on+the+risk+of+vertebral+fracture+in+women+with+postmenopausal+osteoporosis&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Meunier+PJ%2C+Roux+C%2C+Seeman+E%2C+%27%27et+al%27%27&amp;rft.au=Meunier+PJ%2C+Roux+C%2C+Seeman+E%2C+%27%27et+al%27%27&amp;rft.date=2004&amp;rft.volume=350&amp;rft.issue=5&amp;rft.pages=459%E2%80%9368&amp;rft_id=info:doi/10.1056%2FNEJMoa022436&amp;rft_id=info:pmid/14749454&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-35"><b><a href="#cite_ref-35" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFO.27Donnell_S.2C_Cranney_A.2C_Wells_GA.2C_Adachi_JD.2C_Reginster_JY2006">O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY (2006). "Strontium ranelate for preventing and treating postmenopausal osteoporosis". <i>Cochrane database of systematic reviews (Online)</i> (4): CD005326. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F14651858.CD005326.pub3" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD005326.pub3" rel="nofollow">10.1002/14651858.CD005326.pub3</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17054253" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17054253">PMID 17054253</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Strontium+ranelate+for+preventing+and+treating+postmenopausal+osteoporosis&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.aulast=O%27Donnell+S%2C+Cranney+A%2C+Wells+GA%2C+Adachi+JD%2C+Reginster+JY&amp;rft.au=O%27Donnell+S%2C+Cranney+A%2C+Wells+GA%2C+Adachi+JD%2C+Reginster+JY&amp;rft.date=2006&amp;rft.issue=4&amp;rft.pages=CD005326&amp;rft_id=info:doi/10.1002%2F14651858.CD005326.pub3&amp;rft_id=info:pmid/17054253&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-36"><b><a href="#cite_ref-36" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFReginster_JY.2C_Seeman_E.2C_De_Vernejoul_MC.2C_.27.27et_al.27.272005">Reginster JY, Seeman E, De Vernejoul MC, <i>et al</i> (2005). "Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study.". <i>J Clin Endorinol Metab</i> <b>90</b>: 2816–22. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15728210" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15728210">PMID 15728210</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Strontium+ranelate+reduces+the+risk+of+nonvertebral+fractures+in+postmenopausal+women+with+osteoporosis%3A+treatment+of+peripheral+osteoporosis+%28TROPOS%29+study.&amp;rft.jtitle=J+Clin+Endorinol+Metab&amp;rft.aulast=Reginster+JY%2C+Seeman+E%2C+De+Vernejoul+MC%2C+%27%27et+al%27%27&amp;rft.au=Reginster+JY%2C+Seeman+E%2C+De+Vernejoul+MC%2C+%27%27et+al%27%27&amp;rft.date=2005&amp;rft.volume=90&amp;rft.pages=2816%E2%80%9322&amp;rft_id=info:pmid/15728210&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-37"><b><a href="#cite_ref-37" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBlake_GM.2C_Fogelman_I2007">Blake GM, Fogelman I (2007). "The correction of BMD measurements for bone strontium content". <i>J Clin Densitom</i> <b>10</b> (3): 259–65. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.jocd.2007.03.102" class="external text" title="http://dx.doi.org/10.1016%2Fj.jocd.2007.03.102" rel="nofollow">10.1016/j.jocd.2007.03.102</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17543560" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17543560">PMID 17543560</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+correction+of+BMD+measurements+for+bone+strontium+content&amp;rft.jtitle=J+Clin+Densitom&amp;rft.aulast=Blake+GM%2C+Fogelman+I&amp;rft.au=Blake+GM%2C+Fogelman+I&amp;rft.date=2007&amp;rft.volume=10&amp;rft.issue=3&amp;rft.pages=259%E2%80%9365&amp;rft_id=info:doi/10.1016%2Fj.jocd.2007.03.102&amp;rft_id=info:pmid/17543560&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-38"><b><a href="#cite_ref-38" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTaranta_A.2C_Brama_M.2C_Teti_A.2C_.27.27et_al.27.272002">Taranta A, Brama M, Teti A, <i>et al</i> (February 2002). "<a href="http://linkinghub.elsevier.com/retrieve/pii/S8756328201006858" class="external text" title="http://linkinghub.elsevier.com/retrieve/pii/S8756328201006858" rel="nofollow">The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro</a>". <i>Bone</i> <b>30</b> (2): 368–76. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11856644" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11856644">PMID 11856644</a><span class="printonly">. <a href="http://linkinghub.elsevier.com/retrieve/pii/S8756328201006858" class="external free" title="http://linkinghub.elsevier.com/retrieve/pii/S8756328201006858" rel="nofollow">http://linkinghub.elsevier.com/retrieve/pii/S8756328201006858</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+selective+estrogen+receptor+modulator+raloxifene+regulates+osteoclast+and+osteoblast+activity+in+vitro&amp;rft.jtitle=Bone&amp;rft.aulast=Taranta+A%2C+Brama+M%2C+Teti+A%2C+%27%27et+al%27%27&amp;rft.au=Taranta+A%2C+Brama+M%2C+Teti+A%2C+%27%27et+al%27%27&amp;rft.date=February+2002&amp;rft.volume=30&amp;rft.issue=2&amp;rft.pages=368%E2%80%9376&amp;rft_id=info:pmid/11856644&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS8756328201006858&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-39"><b><a href="#cite_ref-39" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMeunier_PJ.2C_Vignot_E.2C_Garnero_P.2C_.27.27et_al.27.271999">Meunier PJ, Vignot E, Garnero P, <i>et al</i> (1999). "<a href="http://link.springer.de/link/service/journals/00198/bibs/9010004/90100330.htm" class="external text" title="http://link.springer.de/link/service/journals/00198/bibs/9010004/90100330.htm" rel="nofollow">Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group</a>". <i>Osteoporos Int</i> <b>10</b> (4): 330–6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10692984" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10692984">PMID 10692984</a><span class="printonly">. <a href="http://link.springer.de/link/service/journals/00198/bibs/9010004/90100330.htm" class="external free" title="http://link.springer.de/link/service/journals/00198/bibs/9010004/90100330.htm" rel="nofollow">http://link.springer.de/link/service/journals/00198/bibs/9010004/90100330.htm</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Treatment+of+postmenopausal+women+with+osteoporosis+or+low+bone+density+with+raloxifene.+Raloxifene+Study+Group&amp;rft.jtitle=Osteoporos+Int&amp;rft.aulast=Meunier+PJ%2C+Vignot+E%2C+Garnero+P%2C+%27%27et+al%27%27&amp;rft.au=Meunier+PJ%2C+Vignot+E%2C+Garnero+P%2C+%27%27et+al%27%27&amp;rft.date=1999&amp;rft.volume=10&amp;rft.issue=4&amp;rft.pages=330%E2%80%936&amp;rft_id=info:pmid/10692984&amp;rft_id=http%3A%2F%2Flink.springer.de%2Flink%2Fservice%2Fjournals%2F00198%2Fbibs%2F9010004%2F90100330.htm&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-40"><b><a href="#cite_ref-40" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMeunier_PJ.2C_Vignot_E.2C_Garnero_P.2C_.27.27et_al.27.271999">Meunier PJ, Vignot E, Garnero P, <i>et al</i> (1999). "<a href="http://link.springer.de/link/service/journals/00198/bibs/9010004/90100330.htm" class="external text" title="http://link.springer.de/link/service/journals/00198/bibs/9010004/90100330.htm" rel="nofollow">Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group</a>". <i>Osteoporos Int</i> <b>10</b> (4): 330–6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10692984" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10692984">PMID 10692984</a><span class="printonly">. <a href="http://link.springer.de/link/service/journals/00198/bibs/9010004/90100330.htm" class="external free" title="http://link.springer.de/link/service/journals/00198/bibs/9010004/90100330.htm" rel="nofollow">http://link.springer.de/link/service/journals/00198/bibs/9010004/90100330.htm</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Treatment+of+postmenopausal+women+with+osteoporosis+or+low+bone+density+with+raloxifene.+Raloxifene+Study+Group&amp;rft.jtitle=Osteoporos+Int&amp;rft.aulast=Meunier+PJ%2C+Vignot+E%2C+Garnero+P%2C+%27%27et+al%27%27&amp;rft.au=Meunier+PJ%2C+Vignot+E%2C+Garnero+P%2C+%27%27et+al%27%27&amp;rft.date=1999&amp;rft.volume=10&amp;rft.issue=4&amp;rft.pages=330%E2%80%936&amp;rft_id=info:pmid/10692984&amp;rft_id=http%3A%2F%2Flink.springer.de%2Flink%2Fservice%2Fjournals%2F00198%2Fbibs%2F9010004%2F90100330.htm&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-41"><b><a href="#cite_ref-41" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.niams.nih.gov/Health_Info/Bone/Bone_Health/Nutrition/default.asp" class="external text" title="http://www.niams.nih.gov/Health_Info/Bone/Bone_Health/Nutrition/default.asp" rel="nofollow">"Nutrition and Bone Health"</a>. <a href="/wiki/National_Institute_of_Arthritis_and_Musculoskeletal_and_Skin_Diseases" title="National Institute of Arthritis and Musculoskeletal and Skin Diseases">NIAMS</a>. 2005-11-01<span class="printonly">. <a href="http://www.niams.nih.gov/Health_Info/Bone/Bone_Health/Nutrition/default.asp" class="external free" title="http://www.niams.nih.gov/Health_Info/Bone/Bone_Health/Nutrition/default.asp" rel="nofollow">http://www.niams.nih.gov/Health_Info/Bone/Bone_Health/Nutrition/default.asp</a></span><span class="reference-accessdate">. Retrieved on 2008-01-28</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Nutrition+and+Bone+Health&amp;rft.atitle=&amp;rft.date=2005-11-01&amp;rft.pub=%5B%5BNational+Institute+of+Arthritis+and+Musculoskeletal+and+Skin+Diseases%7CNIAMS%5D%5D&amp;rft_id=http%3A%2F%2Fwww.niams.nih.gov%2FHealth_Info%2FBone%2FBone_Health%2FNutrition%2Fdefault.asp&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Harvard-42"><b><a href="#cite_ref-Harvard_42-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.hsph.harvard.edu/nutritionsource/calcium.html" class="external text" title="http://www.hsph.harvard.edu/nutritionsource/calcium.html" rel="nofollow">"Calcium &amp; Milk"</a>. Harvard School of Public Health. 2007<span class="printonly">. <a href="http://www.hsph.harvard.edu/nutritionsource/calcium.html" class="external free" title="http://www.hsph.harvard.edu/nutritionsource/calcium.html" rel="nofollow">http://www.hsph.harvard.edu/nutritionsource/calcium.html</a></span><span class="reference-accessdate">. Retrieved on 2008-01-28</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Calcium+%26+Milk&amp;rft.atitle=&amp;rft.date=2007&amp;rft.pub=Harvard+School+of+Public+Health&amp;rft_id=http%3A%2F%2Fwww.hsph.harvard.edu%2Fnutritionsource%2Fcalcium.html&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-43"><b><a href="#cite_ref-43" title="">^</a></b> Report of a Joint WHO/FAO/UNU Expert Consultation(2007) <i><a href="http://whqlibdoc.who.int/trs/WHO_TRS_935_eng.pdf" class="external text" title="http://whqlibdoc.who.int/trs/WHO_TRS_935_eng.pdf" rel="nofollow">Protein and amino acid requirements in human nutrition</a></i>, pp224-226. <a href="/wiki/Special:BookSources/9789241209359" class="internal">ISBN 978-92-4-120935-9</a></li>
<li id="cite_note-44"><b><a href="#cite_ref-44" title="">^</a></b> Report of a Joint WHO/FAO/UNU Expert Consultation(2002), <i><a href="http://www.fao.org/DOCREP/004/Y2809E/y2809e0h.htm#bm17" class="external text" title="http://www.fao.org/DOCREP/004/Y2809E/y2809e0h.htm#bm17" rel="nofollow">Human Vitamin and Mineral Requirements</a></i>, pp166-167.</li>
<li id="cite_note-pmid17720017-45">^ <a href="#cite_ref-pmid17720017_45-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17720017_45-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFTang_BM.2C_Eslick_GD.2C_Nowson_C.2C_Smith_C.2C_Bensoussan_A2007">Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A (2007). "Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis". <i>Lancet</i> <b>370</b> (9588): 657–66. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2807%2961342-7" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2807%2961342-7" rel="nofollow">10.1016/S0140-6736(07)61342-7</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17720017" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17720017">PMID 17720017</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Use+of+calcium+or+calcium+in+combination+with+vitamin+D+supplementation+to+prevent+fractures+and+bone+loss+in+people+aged+50+years+and+older%3A+a+meta-analysis&amp;rft.jtitle=Lancet&amp;rft.aulast=Tang+BM%2C+Eslick+GD%2C+Nowson+C%2C+Smith+C%2C+Bensoussan+A&amp;rft.au=Tang+BM%2C+Eslick+GD%2C+Nowson+C%2C+Smith+C%2C+Bensoussan+A&amp;rft.date=2007&amp;rft.volume=370&amp;rft.issue=9588&amp;rft.pages=657%E2%80%9366&amp;rft_id=info:doi/10.1016%2FS0140-6736%2807%2961342-7&amp;rft_id=info:pmid/17720017&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-46"><b><a href="#cite_ref-46" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPrince_RL.2C_Devine_A.2C_Dhaliwal_SS.2C_Dick_IM2006">Prince RL, Devine A, Dhaliwal SS, Dick IM (2006). "Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women". <i>Arch. Intern. Med.</i> <b>166</b> (8): 869–75. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Farchinte.166.8.869" class="external text" title="http://dx.doi.org/10.1001%2Farchinte.166.8.869" rel="nofollow">10.1001/archinte.166.8.869</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16636212" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16636212">PMID 16636212</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+calcium+supplementation+on+clinical+fracture+and+bone+structure%3A+results+of+a+5-year%2C+double-blind%2C+placebo-controlled+trial+in+elderly+women&amp;rft.jtitle=Arch.+Intern.+Med.&amp;rft.aulast=Prince+RL%2C+Devine+A%2C+Dhaliwal+SS%2C+Dick+IM&amp;rft.au=Prince+RL%2C+Devine+A%2C+Dhaliwal+SS%2C+Dick+IM&amp;rft.date=2006&amp;rft.volume=166&amp;rft.issue=8&amp;rft.pages=869%E2%80%9375&amp;rft_id=info:doi/10.1001%2Farchinte.166.8.869&amp;rft_id=info:pmid/16636212&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18198394-47"><b><a href="#cite_ref-pmid18198394_47-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBolland_MJ.2C_Barber_PA.2C_Doughty_RN.2C_.27.27et_al.27.272008">Bolland MJ, Barber PA, Doughty RN, <i>et al</i> (2008). "Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial". <i>BMJ</i> <b>336</b>: 262. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.39440.525752.BE" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.39440.525752.BE" rel="nofollow">10.1136/bmj.39440.525752.BE</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18198394" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18198394">PMID 18198394</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Vascular+events+in+healthy+older+women+receiving+calcium+supplementation%3A+randomised+controlled+trial&amp;rft.jtitle=BMJ&amp;rft.aulast=Bolland+MJ%2C+Barber+PA%2C+Doughty+RN%2C+%27%27et+al%27%27&amp;rft.au=Bolland+MJ%2C+Barber+PA%2C+Doughty+RN%2C+%27%27et+al%27%27&amp;rft.date=2008&amp;rft.volume=336&amp;rft.pages=262&amp;rft_id=info:doi/10.1136%2Fbmj.39440.525752.BE&amp;rft_id=info:pmid/18198394&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-48"><b><a href="#cite_ref-48" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBischoff-Ferrari_HA.2C_Willett_WC.2C_Wong_JB.2C_Giovannucci_E.2C_Dietrich_T.2C_Dawson-Hughes_B2005">Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B (2005). "Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials". <i>JAMA</i> <b>293</b> (18): 2257–64. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.293.18.2257" class="external text" title="http://dx.doi.org/10.1001%2Fjama.293.18.2257" rel="nofollow">10.1001/jama.293.18.2257</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15886381" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15886381">PMID 15886381</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Fracture+prevention+with+vitamin+D+supplementation%3A+a+meta-analysis+of+randomized+controlled+trials&amp;rft.jtitle=JAMA&amp;rft.aulast=Bischoff-Ferrari+HA%2C+Willett+WC%2C+Wong+JB%2C+Giovannucci+E%2C+Dietrich+T%2C+Dawson-Hughes+B&amp;rft.au=Bischoff-Ferrari+HA%2C+Willett+WC%2C+Wong+JB%2C+Giovannucci+E%2C+Dietrich+T%2C+Dawson-Hughes+B&amp;rft.date=2005&amp;rft.volume=293&amp;rft.issue=18&amp;rft.pages=2257%E2%80%9364&amp;rft_id=info:doi/10.1001%2Fjama.293.18.2257&amp;rft_id=info:pmid/15886381&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-49"><b><a href="#cite_ref-49" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFJackson_RD.2C_LaCroix_AZ.2C_Gass_M.2C_.27.27et_al.27.272006">Jackson RD, LaCroix AZ, Gass M, <i>et al</i> (2006). "Calcium plus vitamin D supplementation and the risk of fractures". <i>N. Engl. J. Med.</i> <b>354</b> (7): 669–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa055218" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa055218" rel="nofollow">10.1056/NEJMoa055218</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16481635" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16481635">PMID 16481635</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Calcium+plus+vitamin+D+supplementation+and+the+risk+of+fractures&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Jackson+RD%2C+LaCroix+AZ%2C+Gass+M%2C+%27%27et+al%27%27&amp;rft.au=Jackson+RD%2C+LaCroix+AZ%2C+Gass+M%2C+%27%27et+al%27%27&amp;rft.date=2006&amp;rft.volume=354&amp;rft.issue=7&amp;rft.pages=669%E2%80%9383&amp;rft_id=info:doi/10.1056%2FNEJMoa055218&amp;rft_id=info:pmid/16481635&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-50"><b><a href="#cite_ref-50" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBonaiuti_D.2C_Shea_B.2C_Iovine_R.2C_.27.27et_al.27.272002">Bonaiuti D, Shea B, Iovine R, <i>et al</i> (2002). "Exercise for preventing and treating osteoporosis in postmenopausal women". <i>Cochrane database of systematic reviews (Online)</i> (3): CD000333. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F14651858.CD000333" class="external text" title="http://dx.doi.org/10.1002%2F14651858.CD000333" rel="nofollow">10.1002/14651858.CD000333</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12137611" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12137611">PMID 12137611</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Exercise+for+preventing+and+treating+osteoporosis+in+postmenopausal+women&amp;rft.jtitle=Cochrane+database+of+systematic+reviews+%28Online%29&amp;rft.aulast=Bonaiuti+D%2C+Shea+B%2C+Iovine+R%2C+%27%27et+al%27%27&amp;rft.au=Bonaiuti+D%2C+Shea+B%2C+Iovine+R%2C+%27%27et+al%27%27&amp;rft.date=2002&amp;rft.issue=3&amp;rft.pages=CD000333&amp;rft_id=info:doi/10.1002%2F14651858.CD000333&amp;rft_id=info:pmid/12137611&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-51"><b><a href="#cite_ref-51" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCheng_S.2C_Sipil.C3.A4_S.2C_Taaffe_DR.2C_Puolakka_J.2C_Suominen_H2002">Cheng S, Sipilä S, Taaffe DR, Puolakka J, Suominen H (2002). "Change in bone mass distribution induced by hormone replacement therapy and high-impact physical exercise in post-menopausal women". <i>Bone</i> <b>31</b> (1): 126–35. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS8756-3282%2802%2900794-9" class="external text" title="http://dx.doi.org/10.1016%2FS8756-3282%2802%2900794-9" rel="nofollow">10.1016/S8756-3282(02)00794-9</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12110425" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12110425">PMID 12110425</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Change+in+bone+mass+distribution+induced+by+hormone+replacement+therapy+and+high-impact+physical+exercise+in+post-menopausal+women&amp;rft.jtitle=Bone&amp;rft.aulast=Cheng+S%2C+Sipil%C3%A4+S%2C+Taaffe+DR%2C+Puolakka+J%2C+Suominen+H&amp;rft.au=Cheng+S%2C+Sipil%C3%A4+S%2C+Taaffe+DR%2C+Puolakka+J%2C+Suominen+H&amp;rft.date=2002&amp;rft.volume=31&amp;rft.issue=1&amp;rft.pages=126%E2%80%9335&amp;rft_id=info:doi/10.1016%2FS8756-3282%2802%2900794-9&amp;rft_id=info:pmid/12110425&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-52"><b><a href="#cite_ref-52" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFChien_MY.2C_Wu_YT.2C_Hsu_AT.2C_Yang_RS.2C_Lai_JS2000">Chien MY, Wu YT, Hsu AT, Yang RS, Lai JS (2000). "Efficacy of a 24-week aerobic exercise program for osteopenic postmenopausal women". <i>Calcif. Tissue Int.</i> <b>67</b> (6): 443–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs002230001180" class="external text" title="http://dx.doi.org/10.1007%2Fs002230001180" rel="nofollow">10.1007/s002230001180</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11289692" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11289692">PMID 11289692</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Efficacy+of+a+24-week+aerobic+exercise+program+for+osteopenic+postmenopausal+women&amp;rft.jtitle=Calcif.+Tissue+Int.&amp;rft.aulast=Chien+MY%2C+Wu+YT%2C+Hsu+AT%2C+Yang+RS%2C+Lai+JS&amp;rft.au=Chien+MY%2C+Wu+YT%2C+Hsu+AT%2C+Yang+RS%2C+Lai+JS&amp;rft.date=2000&amp;rft.volume=67&amp;rft.issue=6&amp;rft.pages=443%E2%80%938&amp;rft_id=info:doi/10.1007%2Fs002230001180&amp;rft_id=info:pmid/11289692&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-53"><b><a href="#cite_ref-53" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFIwamoto_J.2C_Takeda_T.2C_Ichimura_S2001">Iwamoto J, Takeda T, Ichimura S (2001). "Effect of exercise training and detraining on bone mineral density in postmenopausal women with osteoporosis". <i>Journal of orthopaedic science&#160;: official journal of the Japanese Orthopaedic Association</i> <b>6</b> (2): 128–32. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2Fs007760100059" class="external text" title="http://dx.doi.org/10.1007%2Fs007760100059" rel="nofollow">10.1007/s007760100059</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11484097" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11484097">PMID 11484097</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effect+of+exercise+training+and+detraining+on+bone+mineral+density+in+postmenopausal+women+with+osteoporosis&amp;rft.jtitle=Journal+of+orthopaedic+science+%3A+official+journal+of+the+Japanese+Orthopaedic+Association&amp;rft.aulast=Iwamoto+J%2C+Takeda+T%2C+Ichimura+S&amp;rft.au=Iwamoto+J%2C+Takeda+T%2C+Ichimura+S&amp;rft.date=2001&amp;rft.volume=6&amp;rft.issue=2&amp;rft.pages=128%E2%80%9332&amp;rft_id=info:doi/10.1007%2Fs007760100059&amp;rft_id=info:pmid/11484097&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-54"><b><a href="#cite_ref-54" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKemmler_W.2C_Engelke_K.2C_Weineck_J.2C_Hensen_J.2C_Kalender_WA2003">Kemmler W, Engelke K, Weineck J, Hensen J, Kalender WA (2003). "The Erlangen Fitness Osteoporosis Prevention Study: a controlled exercise trial in early postmenopausal women with low bone density-first-year results". <i>Archives of physical medicine and rehabilitation</i> <b>84</b> (5): 673–82. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12736880" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12736880">PMID 12736880</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+Erlangen+Fitness+Osteoporosis+Prevention+Study%3A+a+controlled+exercise+trial+in+early+postmenopausal+women+with+low+bone+density-first-year+results&amp;rft.jtitle=Archives+of+physical+medicine+and+rehabilitation&amp;rft.aulast=Kemmler+W%2C+Engelke+K%2C+Weineck+J%2C+Hensen+J%2C+Kalender+WA&amp;rft.au=Kemmler+W%2C+Engelke+K%2C+Weineck+J%2C+Hensen+J%2C+Kalender+WA&amp;rft.date=2003&amp;rft.volume=84&amp;rft.issue=5&amp;rft.pages=673%E2%80%9382&amp;rft_id=info:pmid/12736880&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-55"><b><a href="#cite_ref-55" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKerr_D.2C_Morton_A.2C_Dick_I.2C_Prince_R1996">Kerr D, Morton A, Dick I, Prince R (1996). "Exercise effects on bone mass in postmenopausal women are site-specific and load-dependent". <i>J. Bone Miner. Res.</i> <b>11</b> (2): 218–25. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8822346" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8822346">PMID 8822346</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Exercise+effects+on+bone+mass+in+postmenopausal+women+are+site-specific+and+load-dependent&amp;rft.jtitle=J.+Bone+Miner.+Res.&amp;rft.aulast=Kerr+D%2C+Morton+A%2C+Dick+I%2C+Prince+R&amp;rft.au=Kerr+D%2C+Morton+A%2C+Dick+I%2C+Prince+R&amp;rft.date=1996&amp;rft.volume=11&amp;rft.issue=2&amp;rft.pages=218%E2%80%9325&amp;rft_id=info:pmid/8822346&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Villareal2003-56"><b><a href="#cite_ref-Villareal2003_56-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFVillareal_DT.2C_Binder_EF.2C_Yarasheski_KE.2C_et_al2003">Villareal DT, Binder EF, Yarasheski KE, et al (2003). "Effects of exercise training added to ongoing hormone replacement therapy on bone mineral density in frail elderly women". <i>J Am Geriatr Soc</i> <b>51</b> (7): 985–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1046%2Fj.1365-2389.2003.51312.x" class="external text" title="http://dx.doi.org/10.1046%2Fj.1365-2389.2003.51312.x" rel="nofollow">10.1046/j.1365-2389.2003.51312.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12834519" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12834519">PMID 12834519</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+exercise+training+added+to+ongoing+hormone+replacement+therapy+on+bone+mineral+density+in+frail+elderly+women&amp;rft.jtitle=J+Am+Geriatr+Soc&amp;rft.aulast=Villareal+DT%2C+Binder+EF%2C+Yarasheski+KE%2C+et+al&amp;rft.au=Villareal+DT%2C+Binder+EF%2C+Yarasheski+KE%2C+et+al&amp;rft.date=2003&amp;rft.volume=51&amp;rft.issue=7&amp;rft.pages=985%E2%80%9390&amp;rft_id=info:doi/10.1046%2Fj.1365-2389.2003.51312.x&amp;rft_id=info:pmid/12834519&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Mayo2005-57"><b><a href="#cite_ref-Mayo2005_57-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSinaki_M.2C_Brey_RH.2C_Hughes_CA.2C_Larson_DR.2C_Kaufman_KR2005">Sinaki M, Brey RH, Hughes CA, Larson DR, Kaufman KR (2005). "Significant reduction in risk of falls and back pain in osteoporotic-kyphotic women through a Spinal Proprioceptive Extension Exercise Dynamic (SPEED) program". <i>Mayo Clin Proc</i> <b>80</b> (7): 849–55. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16007888" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16007888">PMID 16007888</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Significant+reduction+in+risk+of+falls+and+back+pain+in+osteoporotic-kyphotic+women+through+a+Spinal+Proprioceptive+Extension+Exercise+Dynamic+%28SPEED%29+program&amp;rft.jtitle=Mayo+Clin+Proc&amp;rft.aulast=Sinaki+M%2C+Brey+RH%2C+Hughes+CA%2C+Larson+DR%2C+Kaufman+KR&amp;rft.au=Sinaki+M%2C+Brey+RH%2C+Hughes+CA%2C+Larson+DR%2C+Kaufman+KR&amp;rft.date=2005&amp;rft.volume=80&amp;rft.issue=7&amp;rft.pages=849%E2%80%9355&amp;rft_id=info:pmid/16007888&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17846439-58"><b><a href="#cite_ref-pmid17846439_58-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCranney_A.2C_Jamal_SA.2C_Tsang_JF.2C_Josse_RG.2C_Leslie_WD2007">Cranney A, Jamal SA, Tsang JF, Josse RG, Leslie WD (2007). "Low bone mineral density and fracture burden in postmenopausal women". <i>CMAJ</i> <b>177</b> (6): 575–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1503%2Fcmaj.070234" class="external text" title="http://dx.doi.org/10.1503%2Fcmaj.070234" rel="nofollow">10.1503/cmaj.070234</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17846439" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17846439">PMID 17846439</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Low+bone+mineral+density+and+fracture+burden+in+postmenopausal+women&amp;rft.jtitle=CMAJ&amp;rft.aulast=Cranney+A%2C+Jamal+SA%2C+Tsang+JF%2C+Josse+RG%2C+Leslie+WD&amp;rft.au=Cranney+A%2C+Jamal+SA%2C+Tsang+JF%2C+Josse+RG%2C+Leslie+WD&amp;rft.date=2007&amp;rft.volume=177&amp;rft.issue=6&amp;rft.pages=575%E2%80%9380&amp;rft_id=info:doi/10.1503%2Fcmaj.070234&amp;rft_id=info:pmid/17846439&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-59"><b><a href="#cite_ref-59" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHannan_EL.2C_Magaziner_J.2C_Wang_JJ.2C_.27.27et_al.27.272001">Hannan EL, Magaziner J, Wang JJ, <i>et al</i> (2001). "Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes". <i>JAMA</i> <b>285</b> (21): 2736–42. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.285.21.2736" class="external text" title="http://dx.doi.org/10.1001%2Fjama.285.21.2736" rel="nofollow">10.1001/jama.285.21.2736</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11386929" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11386929">PMID 11386929</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Mortality+and+locomotion+6+months+after+hospitalization+for+hip+fracture%3A+risk+factors+and+risk-adjusted+hospital+outcomes&amp;rft.jtitle=JAMA&amp;rft.aulast=Hannan+EL%2C+Magaziner+J%2C+Wang+JJ%2C+%27%27et+al%27%27&amp;rft.au=Hannan+EL%2C+Magaziner+J%2C+Wang+JJ%2C+%27%27et+al%27%27&amp;rft.date=2001&amp;rft.volume=285&amp;rft.issue=21&amp;rft.pages=2736%E2%80%9342&amp;rft_id=info:doi/10.1001%2Fjama.285.21.2736&amp;rft_id=info:pmid/11386929&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-60"><b><a href="#cite_ref-60" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBrenneman_SK.2C_Barrett-Connor_E.2C_Sajjan_S.2C_Markson_LE.2C_Siris_ES2006">Brenneman SK, Barrett-Connor E, Sajjan S, Markson LE, Siris ES (2006). "Impact of recent fracture on health-related quality of life in postmenopausal women". <i>J. Bone Miner. Res.</i> <b>21</b> (6): 809–16. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1359%2Fjbmr.060301" class="external text" title="http://dx.doi.org/10.1359%2Fjbmr.060301" rel="nofollow">10.1359/jbmr.060301</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16753011" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16753011">PMID 16753011</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Impact+of+recent+fracture+on+health-related+quality+of+life+in+postmenopausal+women&amp;rft.jtitle=J.+Bone+Miner.+Res.&amp;rft.aulast=Brenneman+SK%2C+Barrett-Connor+E%2C+Sajjan+S%2C+Markson+LE%2C+Siris+ES&amp;rft.au=Brenneman+SK%2C+Barrett-Connor+E%2C+Sajjan+S%2C+Markson+LE%2C+Siris+ES&amp;rft.date=2006&amp;rft.volume=21&amp;rft.issue=6&amp;rft.pages=809%E2%80%9316&amp;rft_id=info:doi/10.1359%2Fjbmr.060301&amp;rft_id=info:pmid/16753011&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-RiggsEtAl2005-61">^ <a href="#cite_ref-RiggsEtAl2005_61-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-RiggsEtAl2005_61-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFRiggs.2C_B.L..3B_Melton.2C_Lj_3.r.d.2005">Riggs, B.L.; Melton, Lj 3.r.d. (2005). "The worldwide problem of osteoporosis: insights afforded by epidemiology.". <i>Bone</i>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8573428" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8573428">PMID 8573428</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+worldwide+problem+of+osteoporosis%3A+insights+afforded+by+epidemiology.&amp;rft.jtitle=Bone&amp;rft.aulast=Riggs%2C+B.L.%3B+Melton%2C+Lj+3.r.d.&amp;rft.au=Riggs%2C+B.L.%3B+Melton%2C+Lj+3.r.d.&amp;rft.date=2005&amp;rft_id=info:pmid/8573428&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Merkepid-62">^ <a href="#cite_ref-Merkepid_62-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Merkepid_62-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="web"><a href="http://www.merckmedicus.com/pp/us/hcp/diseasemodules/osteoporosis/epidemiology.jsp" class="external text" title="http://www.merckmedicus.com/pp/us/hcp/diseasemodules/osteoporosis/epidemiology.jsp" rel="nofollow">"MerckMedicus Modules: Osteoporosis - Epidemiology"</a>. Merck &amp; Co., Inc<span class="printonly">. <a href="http://www.merckmedicus.com/pp/us/hcp/diseasemodules/osteoporosis/epidemiology.jsp" class="external free" title="http://www.merckmedicus.com/pp/us/hcp/diseasemodules/osteoporosis/epidemiology.jsp" rel="nofollow">http://www.merckmedicus.com/pp/us/hcp/diseasemodules/osteoporosis/epidemiology.jsp</a></span><span class="reference-accessdate">. Retrieved on 2008-06-13</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=MerckMedicus+Modules%3A+Osteoporosis+-+Epidemiology&amp;rft.atitle=&amp;rft.pub=Merck+%26+Co.%2C+Inc&amp;rft_id=http%3A%2F%2Fwww.merckmedicus.com%2Fpp%2Fus%2Fhcp%2Fdiseasemodules%2Fosteoporosis%2Fepidemiology.jsp&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-63"><b><a href="#cite_ref-63" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCauley_JA.2C_Hochberg_MC.2C_Lui_LY_.27.27et_al.27.272007">Cauley JA, Hochberg MC, Lui LY <i>et al</i> (2007). "Long-term Risk of Incident Vertebral Fractures". <i>JAMA</i> <b>298</b>: 2761–2767. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.298.23.2761" class="external text" title="http://dx.doi.org/10.1001%2Fjama.298.23.2761" rel="nofollow">10.1001/jama.298.23.2761</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18165669" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18165669">PMID 18165669</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Long-term+Risk+of+Incident+Vertebral+Fractures&amp;rft.jtitle=JAMA&amp;rft.aulast=Cauley+JA%2C+Hochberg+MC%2C+Lui+LY+%27%27et+al%27%27&amp;rft.au=Cauley+JA%2C+Hochberg+MC%2C+Lui+LY+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=298&amp;rft.pages=2761%E2%80%932767&amp;rft_id=info:doi/10.1001%2Fjama.298.23.2761&amp;rft_id=info:pmid/18165669&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid3259410-64"><b><a href="#cite_ref-pmid3259410_64-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDalsky_GP.2C_Stocke_KS.2C_Ehsani_AA.2C_Slatopolsky_E.2C_Lee_WC.2C_Birge_SJ1988">Dalsky GP, Stocke KS, Ehsani AA, Slatopolsky E, Lee WC, Birge SJ (1988). "Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women". <i>Ann. Intern. Med.</i> <b>108</b> (6): 824–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/3259410" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/3259410">PMID 3259410</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Weight-bearing+exercise+training+and+lumbar+bone+mineral+content+in+postmenopausal+women&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.aulast=Dalsky+GP%2C+Stocke+KS%2C+Ehsani+AA%2C+Slatopolsky+E%2C+Lee+WC%2C+Birge+SJ&amp;rft.au=Dalsky+GP%2C+Stocke+KS%2C+Ehsani+AA%2C+Slatopolsky+E%2C+Lee+WC%2C+Birge+SJ&amp;rft.date=1988&amp;rft.volume=108&amp;rft.issue=6&amp;rft.pages=824%E2%80%938&amp;rft_id=info:pmid/3259410&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-65"><b><a href="#cite_ref-65" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFeskanich_D.2C_Willett_WC.2C_Stampfer_MJ.2C_Colditz_GA1996">Feskanich D, Willett WC, Stampfer MJ, Colditz GA (1996). "Protein consumption and bone fractures in women". <i>Am. J. Epidemiol.</i> <b>143</b> (5): 472–9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8610662" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8610662">PMID 8610662</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Protein+consumption+and+bone+fractures+in+women&amp;rft.jtitle=Am.+J.+Epidemiol.&amp;rft.aulast=Feskanich+D%2C+Willett+WC%2C+Stampfer+MJ%2C+Colditz+GA&amp;rft.au=Feskanich+D%2C+Willett+WC%2C+Stampfer+MJ%2C+Colditz+GA&amp;rft.date=1996&amp;rft.volume=143&amp;rft.issue=5&amp;rft.pages=472%E2%80%939&amp;rft_id=info:pmid/8610662&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12936953-66"><b><a href="#cite_ref-pmid12936953_66-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKerstetter_JE.2C_O.27Brien_KO.2C_Insogna_KL2003">Kerstetter JE, O'Brien KO, Insogna KL (2003). "Dietary protein, calcium metabolism, and skeletal homeostasis revisited". <i>Am. J. Clin. Nutr.</i> <b>78</b> (3 Suppl): 584S–592S. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12936953" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12936953">PMID 12936953</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Dietary+protein%2C+calcium+metabolism%2C+and+skeletal+homeostasis+revisited&amp;rft.jtitle=Am.+J.+Clin.+Nutr.&amp;rft.aulast=Kerstetter+JE%2C+O%27Brien+KO%2C+Insogna+KL&amp;rft.au=Kerstetter+JE%2C+O%27Brien+KO%2C+Insogna+KL&amp;rft.date=2003&amp;rft.volume=78&amp;rft.issue=3+Suppl&amp;rft.pages=584S%E2%80%93592S&amp;rft_id=info:pmid/12936953&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-67"><b><a href="#cite_ref-67" title="">^</a></b> Lobstein JGCFM. <i>Lehrbuch der pathologischen Anatomie.</i> Stuttgart: Bd II, 1835.</li>
<li id="cite_note-68"><b><a href="#cite_ref-68" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAlbright_F.2C_Bloomberg_E.2C_Smith_PH1940">Albright F, Bloomberg E, Smith PH (1940). "Postmenopausal osteoporosis". <i>Trans. Assoc. Am. Physicians.</i> <b>55</b>: 298–305.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Postmenopausal+osteoporosis&amp;rft.jtitle=Trans.+Assoc.+Am.+Physicians.&amp;rft.aulast=Albright+F%2C+Bloomberg+E%2C+Smith+PH&amp;rft.au=Albright+F%2C+Bloomberg+E%2C+Smith+PH&amp;rft.date=1940&amp;rft.volume=55&amp;rft.pages=298%E2%80%93305&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-69"><b><a href="#cite_ref-69" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPatlak_M2001">Patlak M (2001). "Bone builders: the discoveries behind preventing and treating osteoporosis". <i>Faseb J.</i> <b>15</b> (10): 1677E–E. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1096%2Ffj.15.10.1677e" class="external text" title="http://dx.doi.org/10.1096%2Ffj.15.10.1677e" rel="nofollow">10.1096/fj.15.10.1677e</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11481214" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11481214">PMID 11481214</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bone+builders%3A+the+discoveries+behind+preventing+and+treating+osteoporosis&amp;rft.jtitle=Faseb+J.&amp;rft.aulast=Patlak+M&amp;rft.au=Patlak+M&amp;rft.date=2001&amp;rft.volume=15&amp;rft.issue=10&amp;rft.pages=1677E%E2%80%93E&amp;rft_id=info:doi/10.1096%2Ffj.15.10.1677e&amp;rft_id=info:pmid/11481214&amp;rfr_id=info:sid/en.wikipedia.org:Osteoporosis"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-70"><b><a href="#cite_ref-70" title="">^</a></b> <a href="http://www.nos.org.uk/NetCommunity/Page.aspx?pid=223&amp;srcid=183" class="external text" title="http://www.nos.org.uk/NetCommunity/Page.aspx?pid=223&amp;srcid=183" rel="nofollow">"About Us"</a>, National Osteoporosis Society.</li>
<li id="cite_note-Medical_News_Today-71"><b><a href="#cite_ref-Medical_News_Today_71-0" title="">^</a></b> <a href="http://www.medicalnewstoday.com/articles/100809.php" class="external text" title="http://www.medicalnewstoday.com/articles/100809.php" rel="nofollow">"£3million Award Towards The Improvement Of Osteoporosis Services, UK"</a>, <a href="/wiki/Medical_News_Today" title="Medical News Today">Medical News Today</a>, 17 March 2008.</li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Osteoporosis&amp;action=edit&amp;section=30" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.dmoz.org/Health/Conditions_and_Diseases/Musculoskeletal_Disorders/Osteoporosis//" class="external text" title="http://www.dmoz.org/Health/Conditions_and_Diseases/Musculoskeletal_Disorders/Osteoporosis//" rel="nofollow">Osteoporosis</a> at the <a href="/wiki/Open_Directory_Project" title="Open Directory Project">Open Directory Project</a></li>
<li><a href="http://osteoed.org/tools.php" class="external text" title="http://osteoed.org/tools.php" rel="nofollow">Osteoporosis risk assessment tools</a></li>
<li><a href="http://www.who.int/nutrition/topics/5_population_nutrient/en/index25.html" class="external text" title="http://www.who.int/nutrition/topics/5_population_nutrient/en/index25.html" rel="nofollow">Diet, Nutrition and the prevention of osteoporosis</a> the <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> and <a href="/wiki/Food_and_Agriculture_Organization" title="Food and Agriculture Organization">Food and Agriculture Organization</a> (2003)</li>
<li><a href="http://www.surgeongeneral.gov/library/bonehealth/" class="external text" title="http://www.surgeongeneral.gov/library/bonehealth/" rel="nofollow">Bone Health and Osteoporosis: A Report of the Surgeon General</a> distributed by the U.S. <a href="/wiki/Department_of_Health_and_Human_Services" title="Department of Health and Human Services" class="mw-redirect">Department of Health and Human Services</a></li>
<li><a href="http://www.nof.org" class="external text" title="http://www.nof.org" rel="nofollow">NOF.org</a> <a href="/wiki/The_National_Osteoporosis_Foundation" title="The National Osteoporosis Foundation" class="mw-redirect">The National Osteoporosis Foundation</a></li>
<li><a href="http://www.nos.org.uk" class="external text" title="http://www.nos.org.uk" rel="nofollow">NOS.org.uk</a> <a href="/wiki/National_Osteoporosis_Society" title="National Osteoporosis Society">National Osteoporosis Society</a> (UK)</li>
</ul>
<p><br /></p>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:Silver" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:Silver;border:none;; font-size:xx-small;"><a href="/wiki/Template:Osteochondropathy" title="Template:Osteochondropathy"><span title="View this template" style=";background:Silver;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/w/index.php?title=Template_talk:Osteochondropathy&amp;action=edit&amp;redlink=1" class="new" title="Template talk:Osteochondropathy (page does not exist)"><span title="Discussion about this template" style=";background:Silver;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Osteochondropathy&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Osteochondropathy&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:Silver;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Osteochondropathy" title="Osteochondropathy">Osteochondropathy</a> (<a href="/wiki/ICD-10_Chapter_XIII:_Diseases_of_the_musculoskeletal_system_and_connective_tissue#.28M80-M90.29_Osteopathies" title="ICD-10 Chapter XIII: Diseases of the musculoskeletal system and connective tissue">M80-M94</a>, <a href="/wiki/List_of_ICD-9_codes_710-739:_Diseases_of_the_musculoskeletal_system_and_connective_tissue#osteopathies.2C_chondropathies.2C_and_acquired_musculoskeletal_deformities_.28730-739.29" title="List of ICD-9 codes 710-739: Diseases of the musculoskeletal system and connective tissue" class="mw-redirect">730-733</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: WhiteSmoke;"><a href="/wiki/Bone_disease" title="Bone disease">Osteopathies</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;"><a href="/wiki/Osteitis" title="Osteitis">Osteitis</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Endocrine_bone_disease" title="Endocrine bone disease">endocrine bone disease</a>:</i> <a href="/wiki/Osteitis_fibrosa_cystica" title="Osteitis fibrosa cystica">Osteitis fibrosa cystica</a> (<a href="/wiki/Brown_tumor" title="Brown tumor">Brown tumor</a>)<br />
<i><a href="/wiki/Infectious_bone_disease" title="Infectious bone disease">infectious bone disease</a>:</i> <a href="/wiki/Osteomyelitis" title="Osteomyelitis">Osteomyelitis</a> (<a href="/wiki/Sequestrum" title="Sequestrum">Sequestrum</a>, <a href="/wiki/Involucrum" title="Involucrum">Involucrum</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Sesamoiditis" title="Sesamoiditis">Sesamoiditis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Brodie_abscess" title="Brodie abscess">Brodie abscess</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Periostitis" title="Periostitis">Periostitis</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;"><a href="/wiki/Bone_density" title="Bone density">Bone density</a><br />
and structure</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;">Density / <a href="/wiki/Metabolic_bone_disease" title="Metabolic bone disease">metabolic bone disease</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><strong class="selflink">Osteoporosis</strong><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Osteopenia" title="Osteopenia">Osteopenia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Osteomalacia" title="Osteomalacia">Osteomalacia</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;">Continuity of bone</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Pseudarthrosis" title="Pseudarthrosis">Pseudarthrosis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Stress_fracture" title="Stress fracture">Stress fracture</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;">Other</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Fibrous_dysplasia" title="Fibrous dysplasia" class="mw-redirect">Fibrous dysplasia</a> (<a href="/wiki/Monostotic_fibrous_dysplasia" title="Monostotic fibrous dysplasia">Monostotic</a>, <a href="/wiki/Polyostotic_fibrous_dysplasia" title="Polyostotic fibrous dysplasia">Polyostotic</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Skeletal_fluorosis" title="Skeletal fluorosis">Skeletal fluorosis</a><span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Bone_cyst" title="Bone cyst">bone cyst</a></i> (<a href="/wiki/Aneurysmal_bone_cyst" title="Aneurysmal bone cyst">Aneurysmal bone cyst</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hyperostosis" title="Hyperostosis">Hyperostosis</a> (<a href="/wiki/Infantile_cortical_hyperostosis" title="Infantile cortical hyperostosis">Infantile cortical hyperostosis</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Osteosclerosis" title="Osteosclerosis">Osteosclerosis</a> (<a href="/wiki/Melorheostosis" title="Melorheostosis">Melorheostosis</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;"><a href="/wiki/Bone_resorption" title="Bone resorption">Bone resorption</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Osteolysis" title="Osteolysis">Osteolysis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hajdu-Cheney_syndrome" title="Hajdu-Cheney syndrome">Hajdu-Cheney syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Ainhum" title="Ainhum">Ainhum</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;"><a href="/wiki/Ischemia" title="Ischemia">Ischemia</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Avascular_necrosis" title="Avascular necrosis">Avascular necrosis</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;">Other</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Paget%27s_disease_of_bone" title="Paget's disease of bone">Paget's disease of bone</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Complex_regional_pain_syndrome" title="Complex regional pain syndrome">Algoneurodystrophy</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hypertrophic_pulmonary_osteoarthropathy" title="Hypertrophic pulmonary osteoarthropathy">Hypertrophic pulmonary osteoarthropathy</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Nonossifying_fibroma" title="Nonossifying fibroma">Nonossifying fibroma</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: WhiteSmoke;"><a href="/wiki/Chondropathy" title="Chondropathy">Chondropathies</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;"><a href="/wiki/Chondritis" title="Chondritis">Chondritis</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Relapsing_polychondritis" title="Relapsing polychondritis">Relapsing polychondritis</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;">Other</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Tietze%27s_syndrome" title="Tietze's syndrome" class="mw-redirect">Tietze's syndrome</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: WhiteSmoke;">Both</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;"><a href="/wiki/Osteochondritis" title="Osteochondritis">Osteochondritis</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Osteochondritis_dissecans" title="Osteochondritis dissecans">Osteochondritis dissecans</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: WhiteSmoke;">
<div style="padding:0em 0.75em;"><a href="/wiki/Osteochondrosis" title="Osteochondrosis">Juvenile osteochondrosis</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Legg%E2%80%93Calv%C3%A9%E2%80%93Perthes_syndrome" title="Legg–Calvé–Perthes syndrome">Legg–Calvé–Perthes syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Osgood-Schlatter_disease" title="Osgood-Schlatter disease">Osgood-Schlatter disease</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Blount%27s_disease" title="Blount's disease">Blount's disease</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/K%C3%B6hler_disease" title="Köhler disease">Köhler disease</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Sever%27s_disease" title="Sever's disease">Sever's disease</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Kienbock%27s_disease" title="Kienbock's disease">Kienbock's disease</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i>see also <a href="/wiki/Template:Osteochondrodysplasia" title="Template:Osteochondrodysplasia">osteochondrodysplasia</a>, <a href="/wiki/Template:Osseous_and_chondromatous_tumors" title="Template:Osseous and chondromatous tumors">neoplasia</a></i></div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 35599/1000000
Post-expand include size: 338343/2048000 bytes
Template argument size: 140996/2048000 bytes
Expensive parser function count: 7/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:22461-0!1!0!default!!en!2 and timestamp 20090406062346 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Osteoporosis">http://en.wikipedia.org/wiki/Osteoporosis</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Aging-associated_diseases" title="Category:Aging-associated diseases">Aging-associated diseases</a></span> | <span dir='ltr'><a href="/wiki/Category:Endocrinology" title="Category:Endocrinology">Endocrinology</a></span> | <span dir='ltr'><a href="/wiki/Category:Skeletal_disorders" title="Category:Skeletal disorders">Skeletal disorders</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_May_2008" title="Category:Articles with unsourced statements since May 2008">Articles with unsourced statements since May 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_September_2007" title="Category:Articles with unsourced statements since September 2007">Articles with unsourced statements since September 2007</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2005" title="Category:Articles containing potentially dated statements from 2005">Articles containing potentially dated statements from 2005</a></span> | <span dir='ltr'><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_April_2008" title="Category:Articles with unsourced statements since April 2008">Articles with unsourced statements since April 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_February_2008" title="Category:Articles with unsourced statements since February 2008">Articles with unsourced statements since February 2008</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Osteoporosis" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Osteoporosis" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Osteoporosis&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Osteoporosis&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Osteoporosis" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Osteoporosis" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Osteoporosis" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Osteoporosis&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Osteoporosis&amp;oldid=282051990" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Osteoporosis&amp;id=282051990">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-ar"><a href="http://ar.wikipedia.org/wiki/%D9%88%D9%87%D9%86_%D8%A7%D9%84%D8%B9%D8%B8%D8%A7%D9%85">العربية</a></li>
				<li class="interwiki-bg"><a href="http://bg.wikipedia.org/wiki/%D0%9E%D1%81%D1%82%D0%B5%D0%BE%D0%BF%D0%BE%D1%80%D0%BE%D0%B7%D0%B0">Български</a></li>
				<li class="interwiki-ca"><a href="http://ca.wikipedia.org/wiki/Osteoporosi">Català</a></li>
				<li class="interwiki-cs"><a href="http://cs.wikipedia.org/wiki/Osteopor%C3%B3za">Česky</a></li>
				<li class="interwiki-da"><a href="http://da.wikipedia.org/wiki/Osteoporose">Dansk</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Osteoporose">Deutsch</a></li>
				<li class="interwiki-el"><a href="http://el.wikipedia.org/wiki/%CE%9F%CF%83%CF%84%CE%B5%CE%BF%CF%80%CF%8C%CF%81%CF%89%CF%83%CE%B7">Ελληνικά</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Osteoporosis">Español</a></li>
				<li class="interwiki-fa"><a href="http://fa.wikipedia.org/wiki/%D9%BE%D9%88%DA%A9%DB%8C_%D8%A7%D8%B3%D8%AA%D8%AE%D9%88%D8%A7%D9%86">فارسی</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Ost%C3%A9oporose">Français</a></li>
				<li class="interwiki-ko"><a href="http://ko.wikipedia.org/wiki/%EA%B3%A8%EB%8B%A4%EA%B3%B5%EC%A6%9D">한국어</a></li>
				<li class="interwiki-hr"><a href="http://hr.wikipedia.org/wiki/Osteoporoza">Hrvatski</a></li>
				<li class="interwiki-id"><a href="http://id.wikipedia.org/wiki/Osteoporosis">Bahasa Indonesia</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Osteoporosi">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/%D7%93%D7%9C%D7%93%D7%95%D7%9C_%D7%A2%D7%A6%D7%9D">עברית</a></li>
				<li class="interwiki-ka"><a href="http://ka.wikipedia.org/wiki/%E1%83%9D%E1%83%A1%E1%83%A2%E1%83%94%E1%83%9D%E1%83%9E%E1%83%9D%E1%83%A0%E1%83%9D%E1%83%96%E1%83%98">ქართული</a></li>
				<li class="interwiki-la"><a href="http://la.wikipedia.org/wiki/Osteoporosis">Latina</a></li>
				<li class="interwiki-lv"><a href="http://lv.wikipedia.org/wiki/Osteoporoze">Latviešu</a></li>
				<li class="interwiki-lt"><a href="http://lt.wikipedia.org/wiki/Osteoporoz%C4%97">Lietuvių</a></li>
				<li class="interwiki-ms"><a href="http://ms.wikipedia.org/wiki/Osteoporosis">Bahasa Melayu</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Osteoporose">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E9%AA%A8%E7%B2%97%E9%AC%86%E7%97%87">日本語</a></li>
				<li class="interwiki-no"><a href="http://no.wikipedia.org/wiki/Osteoporose">‪Norsk (bokmål)‬</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Osteoporoza">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Osteoporose">Português</a></li>
				<li class="interwiki-ro"><a href="http://ro.wikipedia.org/wiki/Osteoporoz%C4%83">Română</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%9E%D1%81%D1%82%D0%B5%D0%BE%D0%BF%D0%BE%D1%80%D0%BE%D0%B7">Русский</a></li>
				<li class="interwiki-sl"><a href="http://sl.wikipedia.org/wiki/Osteoporoza">Slovenščina</a></li>
				<li class="interwiki-sh"><a href="http://sh.wikipedia.org/wiki/Osteoporoza">Srpskohrvatski / Српскохрватски</a></li>
				<li class="interwiki-su"><a href="http://su.wikipedia.org/wiki/Ost%C3%A9oporosis">Basa Sunda</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Osteoporoosi">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Bensk%C3%B6rhet">Svenska</a></li>
				<li class="interwiki-th"><a href="http://th.wikipedia.org/wiki/%E0%B8%A0%E0%B8%B2%E0%B8%A7%E0%B8%B0%E0%B8%81%E0%B8%A3%E0%B8%B0%E0%B8%94%E0%B8%B9%E0%B8%81%E0%B8%9E%E0%B8%A3%E0%B8%B8%E0%B8%99">ไทย</a></li>
				<li class="interwiki-tr"><a href="http://tr.wikipedia.org/wiki/Osteoporoz">Türkçe</a></li>
				<li class="interwiki-uk"><a href="http://uk.wikipedia.org/wiki/%D0%9E%D1%81%D1%82%D0%B5%D0%BE%D0%BF%D0%BE%D1%80%D0%BE%D0%B7">Українська</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E9%AA%A8%E8%B3%AA%E7%96%8F%E9%AC%86%E7%97%87">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 6 April 2009, at 06:23.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv141 in 0.082 secs. --></body></html>
